Advanced search
Publication Cover
Critical Reviews in Biochemistry and Molecular Biology Volume 55, 2020 - Issue 2
Submit an article Journal homepage
1,987
Views
33
CrossRef citations to date
0
Altmetric
Review Articles

Protease propeptide structures, mechanisms of activation, and functions

Lise BoonRega Institute for Medical Research, Department of Microbiology, Immunology and Transplantation, Laboratory of Immunobiology, KU Leuven, Leuven, BelgiumView further author information
,
Estefania Ugarte-BerzalRega Institute for Medical Research, Department of Microbiology, Immunology and Transplantation, Laboratory of Immunobiology, KU Leuven, Leuven, BelgiumView further author information
,
Jennifer VandoorenRega Institute for Medical Research, Department of Microbiology, Immunology and Transplantation, Laboratory of Immunobiology, KU Leuven, Leuven, BelgiumView further author information
&
Ghislain OpdenakkerRega Institute for Medical Research, Department of Microbiology, Immunology and Transplantation, Laboratory of Immunobiology, KU Leuven, Leuven, BelgiumCorrespondence[email protected]
View further author information
Pages 111-165 | Received 24 Dec 2019, Accepted 10 Mar 2020, Published online: 14 Apr 2020

References

  • Abifadel M, Varret M, Rabes JP, Allard D, Ouguerram K, Devillers M, Cruaud C, Benjannet S, Wickham L, Erlich D, et al. 2003. Mutations in PCSK9 cause autosomal dominant hypercholesterolemia. Nat Genet. 34(2):154–156.
  • Adkison AM, Raptis SZ, Kelley DG, Pham CT. 2002. Dipeptidyl peptidase I activates neutrophil-derived serine proteases and regulates the development of acute experimental arthritis. J Clin Invest. 109(3):363–371.
  • Afar DE, Vivanco I, Hubert RS, Kuo J, Chen E, Saffran DC, Raitano AB, Jakobovits A. 2001. Catalytic cleavage of the androgen-regulated TMPRSS2 protease results in its secretion by prostate and prostate cancer epithelia. Cancer Res. 61(4):1686–1692.
  • Albrechtsen R, Kveiborg M, Stautz D, Vikesa J, Noer JB, Kotzsh A, Nielsen FC, Wewer UM, Frohlich C. 2013. ADAM12 redistributes and activates MMP-14, resulting in gelatin degradation, reduced apoptosis and increased tumor growth. J Cell Sci. 126(Pt 20):4707–4720.
  • Ali MA, Schulz R. 2009. Activation of MMP-2 as a key event in oxidative stress injury to the heart. Front Biosci. 14:699–716.
  • Al-Janabi J, Hartsuck JA, Tang J. 1972. Kinetics and mechanism of pepsinogen activation. J Biol Chem. 247(14):4628–4632.
  • Allsopp TE, McLuckie J, Kerr LE, Macleod M, Sharkey J, Kelly JS. 2000. Caspase 6 activity initiates caspase 3 activation in cerebellar granule cell apoptosis. Cell Death Differ. 7(10):984–993.
  • Altamura S, D’Alessio F, Selle B, Muckenthaler MU. 2010. A novel TMPRSS6 mutation that prevents protease auto-activation causes IRIDA. Biochem J. 431(3):363–371.
  • Altincicek B, Shibamiya A, Trusheim H, Tzima E, Niepmann M, Linder D, Preissner KT, Kanse SM. 2006. A positively charged cluster in the epidermal growth factor-like domain of Factor VII-activating protease (FSAP) is essential for polyanion binding. Biochem J. 394(Pt 3):687–692.
  • Anders A, Gilbert S, Garten W, Postina R, Fahrenholz F. 2001. Regulation of the alpha-secretase ADAM10 by its prodomain and proprotein convertases. FASEB J. 15(10):1837–1839.
  • Anderson ED, Molloy SS, Jean F, Fei H, Shimamura S, Thomas G. 2002. The ordered and compartment-specific autoproteolytic removal of the furin intramolecular chaperone is required for enzyme activation. J Biol Chem. 277(15):12879–12890.
  • Anderson ED, VanSlyke JK, Thulin CD, Jean F, Thomas G. 1997. Activation of the furin endoprotease is a multiple-step process: requirements for acidification and internal propeptide cleavage. Embo J. 16(7):1508–1518.
  • Apte SS. 2009. A disintegrin-like and metalloprotease (reprolysin-type) with thrombospondin type 1 motif (ADAMTS) superfamily: functions and mechanisms. J Biol Chem. 284(46):31493–31497.
  • Ardi VC, Kupriyanova TA, Deryugina EI, Quigley JP. 2007. Human neutrophils uniquely release TIMP-free MMP-9 to provide a potent catalytic stimulator of angiogenesis. Proc Natl Acad Sci USA. 104(51):20262–20267.
  • Ardi VC, Van den Steen PE, Opdenakker G, Schweighofer B, Deryugina EI, Quigley JP. 2009. Neutrophil MMP-9 proenzyme, unencumbered by TIMP-1, undergoes efficient activation in vivo and catalytically induces angiogenesis via a basic fibroblast growth factor (FGF-2)/FGFR-2 pathway. J Biol Chem. 284(38):25854–25866.
  • Arendt CS, Hochstrasser M. 1999. Eukaryotic 20S proteasome catalytic subunit propeptides prevent active site inactivation by N-terminal acetylation and promote particle assembly. EMBO J. 18(13):3575–3585.
  • Arlaud GJ, Gagnon J. 1985. Identification of the peptide bond cleaved during activation of human C1r. FEBS Lett. 180(2):234–238.
  • Ashkenazi A, Dixit VM. 1998. Death receptors: signaling and modulation. Science. 281(5381):1305–1308.
  • Azuma T, Pals G, Mohandas TK, Couvreur JM, Taggart RT. 1989. Human gastric cathepsin E. Predicted sequence, localization to chromosome 1, and sequence homology with other aspartic proteinases. J Biol Chem. 264(28):16748–16753.
  • Baici A, Muntener K, Willimann A, Zwicky R. 2006. Regulation of human cathepsin B by alternative mRNA splicing: homeostasis, fatal errors and cell death. Biol Chem. 387(8):1017–1021.
  • Bainton DF. 1981. The discovery of lysosomes. J Cell Biol. 91(3):66s–76s.
  • Bajzar L, Manuel R, Nesheim ME. 1995. Purification and characterization of TAFI, a thrombin-activable fibrinolysis inhibitor. J Biol Chem. 270(24):14477–14484.
  • Bannikov GA, Karelina TV, Collier IE, Marmer BL, Goldberg GI. 2002. Substrate binding of gelatinase B induces its enzymatic activity in the presence of intact propeptide. J Biol Chem. 277(18):16022–16027.
  • Barrett AJ, Kirschke H. 1981. Cathepsin B, Cathepsin H, and cathepsin L. Meth Enzymol. 80(Pt C):535–561.
  • Basak A, Toure BB, Lazure C, Mbikay M, Chretien M, Seidah NG. 1999. Enzymic characterization in vitro of recombinant proprotein convertase PC4. Biochem J. 343(1):29–37.
  • Becker-Pauly C, Howel M, Walker T, Vlad A, Aufenvenne K, Oji V, Lottaz D, Sterchi EE, Debela M, Magdolen V, et al. 2007. The alpha and beta subunits of the metalloprotease meprin are expressed in separate layers of human epidermis, revealing different functions in keratinocyte proliferation and differentiation. J Invest Dermatol. 127(5):1115–1125.
  • Benaud C, Dickson RB, Lin CY. 2001. Regulation of the activity of matriptase on epithelial cell surfaces by a blood-derived factor. Eur J Biochem. 268(5):1439–1447.
  • Benaud CM, Oberst M, Dickson RB, Lin CY. 2002. Deregulated activation of matriptase in breast cancer cells. Clin Exp Metastasis. 19(7):639–649.
  • Benaud C, Oberst M, Hobson JP, Spiegel S, Dickson RB, Lin CY. 2002. Sphingosine 1-phosphate, present in serum-derived lipoproteins, activates matriptase. J Biol Chem. 277(12):10539–10546.
  • Benes P, Vetvicka V, Fusek M. 2008. Cathepsin D – many functions of one aspartic protease. Crit Rev Oncol Hematol. 68(1):12–28.
  • Bennett K, Levine T, Ellis JS, Peanasky RJ, Samloff IM, Kay J, Chain BM. 1992. Antigen processing for presentation by class II major histocompatibility complex requires cleavage by cathepsin E. Eur J Immunol. 22(6):1519–1524.
  • Bergmann M, Fruton JS. 1937. The nature of papain activation. Science. 86(2239):496–497.
  • Billington CJ, Mason P, Magny MC, Mort JS. 2000. The slow-binding inhibition of cathepsin K by its propeptide. Biochem Biophys Res Commun. 276(3):924–929.
  • Bissonnette L, Charest G, Longpre JM, Lavigne P, Leduc R. 2004. Identification of furin pro-region determinants involved in folding and activation. Biochem J. 379(3):757–763.
  • Boatright KM, Renatus M, Scott FL, Sperandio S, Shin H, Pedersen IM, Ricci JE, Edris WA, Sutherlin DP, Green DR, et al. 2003. A unified model for apical caspase activation. Mol Cell. 11(2):529–541.
  • Boatright KM, Salvesen GS. 2003. Mechanisms of caspase activation. Curr Opin Cell Biol. 15(6):725–731.
  • Bode W, Schwager P, Huber R. 1978. The transition of bovine trypsinogen to a trypsin-like state upon strong ligand binding. The refined crystal structures of the bovine trypsinogen-pancreatic trypsin inhibitor complex and of its ternary complex with Ile-Val at 1.9 A resolution. J Mol Biol. 118(1):99–112.
  • Bom VJ, Bertina RM. 1990. The contributions of Ca2+, phospholipids and tissue-factor apoprotein to the activation of human blood-coagulation factor X by activated factor VII. Biochem J. 265(2):327–336.
  • Bond JS, Beynon RJ. 1986. Meprin: a membrane-bound metallo-endopeptidase. Curr Top Cell Regul. 28:263–290.
  • Boon L, Ugarte-Berzal E, Martens E, Vandooren J, Rybakin V, Colau D, Gordon-Alonso M, van der Bruggen P, Stöcker W, Becker-Pauly C, et al. 2019. Propeptide glycosylation and galectin-3 binding decrease proteolytic activation of human proMMP-9/progelatinase B. FEBS J. 286(5):930–945.
  • Bratton SB, Walker G, Srinivasula SM, Sun XM, Butterworth M, Alnemri ES, Cohen GM. 2001. Recruitment, activation and retention of caspases-9 and -3 by Apaf-1 apoptosome and associated XIAP complexes. Embo J. 20(5):998–1009.
  • Brattsand M, Stefansson K, Lundh C, Haasum Y, Egelrud T. 2005. A proteolytic cascade of kallikreins in the stratum corneum. J Invest Dermatol. 124(1):198–203.
  • Bross P, Andresen BS, Knudsen I, Kruse TA, Gregersen N. 1995. Human ClpP protease: cDNA sequence, tissue-specific expression and chromosomal assignment of the gene. FEBS Lett. 377(2):249–252.
  • Burden RE, Snoddy P, Buick RJ, Johnston JA, Walker B, Scott CJ. 2008. Recombinant cathepsin S propeptide attenuates cell invasion by inhibition of cathepsin L-like proteases in tumor microenvironment. Mol Cancer Ther. 7(3):538–547.
  • Burden RE, Snoddy P, Jefferies CA, Walker B, Scott CJ. 2007. Inhibition of cathepsin L-like proteases by cathepsin V propeptide. Biol Chem. 388(5):541–545.
  • Burkart AD, Xiong B, Baibakov B, Jimenez-Movilla M, Dean J. 2012. Ovastacin, a cortical granule protease, cleaves ZP2 in the zona pellucida to prevent polyspermy. J Cell Biol. 197(1):37–44.
  • Butler PE, McKay MJ, Bond JS. 1987. Characterization of meprin, a membrane-bound metalloendopeptidase from mouse kidney. Biochem J. 241(1):229–235.
  • Butt AJ, Harvey NL, Parasivam G, Kumar S. 1998. Dimerization and autoprocessing of the Nedd2 (caspase-2) precursor requires both the prodomain and the carboxyl-terminal regions. J Biol Chem. 273(12):6763–6768.
  • Caglic D, Pungercar JR, Pejler G, Turk V, Turk B. 2007. Glycosaminoglycans facilitate procathepsin B activation through disruption of propeptide-mature enzyme interactions. J Biol Chem. 282(45):33076–33085.
  • Cal S, Quesada V, Garabaya C, Lopez-Otin C. 2003. Polyserase-I, a human polyprotease with the ability to generate independent serine protease domains from a single translation product. Proc Natl Acad Sci USA. 100(16):9185–9190.
  • Cao Y, Kang Q, Zhao Z, Zolkiewska A. 2002. Intracellular processing of metalloprotease disintegrin ADAM12. J Biol Chem. 277(29):26403–26411.
  • Cao Q, Wang XJ, Li LF, Su XD. 2014. The regulatory mechanism of the caspase 6 pro-domain revealed by crystal structure and biochemical assays. Acta Crystallogr D Biol Crystallogr. 70(1):58–67.
  • Cao Q, Wang XJ, Liu CW, Liu DF, Li LF, Gao YQ, Su XD. 2012. Inhibitory mechanism of caspase-6 phosphorylation revealed by crystal structures, molecular dynamics simulations, and biochemical assays. J Biol Chem. 287(19):15371–15379.
  • Capizzi SA, Viss MA, Hummel AM, Fass DN, Specks U. 2003. Effects of carboxy-terminal modifications of proteinase 3 (PR3) on the recognition by PR3-ANCA. Kidney Int. 63(2):756–760.
  • Carmona E, Dufour E, Plouffe C, Takebe S, Mason P, Mort JS, Menard R. 1996. Potency and selectivity of the cathepsin L propeptide as an inhibitor of cysteine proteases. Biochemistry. 35(25):8149–8157.
  • Catterall CF, Lyons A, Sim RB, Day AJ, Harris TJ. 1987. Characterization of primary amino acid sequence of human complement control protein factor I from an analysis of cDNA clones. Biochem J. 242(3):849–856.
  • Cauwe B, Opdenakker G. 2010. Intracellular substrate cleavage: a novel dimension in the biochemistry, biology and pathology of matrix metalloproteinases. Crit Rev Biochem Mol Biol. 45(5):351–423.
  • Chai J, Wu Q, Shiozaki E, Srinivasula SM, Alnemri ES, Shi Y. 2001. Crystal structure of a procaspase-7 zymogen: mechanisms of activation and substrate binding. Cell. 107(3):399–407.
  • Chain BM, Free P, Medd P, Swetman C, Tabor AB, Terrazzini N. 2005. The expression and function of cathepsin E in dendritic cells. J Immunol. 174(4):1791–1800.
  • Chang DW, Xing Z, Capacio VL, Peter ME, Yang X. 2003. Interdimer processing mechanism of procaspase-8 activation. Embo J. 22(16):4132–4142.
  • Chao Y, Shiozaki EN, Srinivasula SM, Rigotti DJ, Fairman R, Shi Y. 2005. Engineering a dimeric caspase-9: a re-evaluation of the induced proximity model for caspase activation. PLoS Biol. 3(6):e183.
  • Chen S, Cao P, Dong N, Peng J, Zhang C, Wang H, Zhou T, Yang J, Zhang Y, Martelli EE, et al. 2015. PCSK6-mediated corin activation is essential for normal blood pressure. Nat Med. 21(9):1048–1053.
  • Chen JM, Ferec C. 2009. Chronic pancreatitis: genetics and pathogenesis. Annu Rev Genom Hum Genet. 10(1):63–87.
  • Chen JM, Ferec C. 2012. Genetics and pathogenesis of chronic pancreatitis: the 2012 update. Clin Res Hepatol Gastroenterol. 36(4):334–340.
  • Chen P, Hochstrasser M. 1996. Autocatalytic subunit processing couples active site formation in the 20S proteasome to completion of assembly. Cell. 86(6):961–972.
  • Chen JM, Kukor Z, Le MC, Toth M, Tsakiris L, Raguenes O, Ferec C, Sahin TM. 2003. Evolution of trypsinogen activation peptides. Mol Biol Evol. 20(11):1767–1777.
  • Choi-Miura NH, Tobe T, Sumiya J, Nakano Y, Sano Y, Mazda T, Tomita M. 1996. Purification and characterization of a novel hyaluronan-binding protein (PHBP) from human plasma: it has three EGF, a kringle and a serine protease domain, similar to hepatocyte growth factor activator. J Biochem. 119(6):1157–1165.
  • Chou JJ, Matsuo H, Duan H, Wagner G. 1998. Solution structure of the RAIDD CARD and model for CARD/CARD interaction in caspase-2 and caspase-9 recruitment. Cell. 94(2):171–180.
  • Chu K, Wu SM, Stanley T, Stafford DW, High KA. 1996. A mutation in the propeptide of Factor IX leads to warfarin sensitivity by a novel mechanism. J Clin Invest. 98(7):1619–1625.
  • Chung DW, Fujikawa K, McMullen BA, Davie EW. 1986. Human plasma prekallikrein, a zymogen to a serine protease that contains four tandem repeats. Biochemistry. 25(9):2410–2417.
  • Cigic B, Dahl SW, Pain RH. 2000. The residual pro-part of cathepsin C fulfills the criteria required for an intramolecular chaperone in folding and stabilizing the human proenzyme. Biochemistry. 39(40):12382–12390.
  • Cigic B, Krizaj I, Kralj B, Turk V, Pain RH. 1998. Stoichiometry and heterogeneity of the pro-region chain in tetrameric human cathepsin C. Biochim Biophys Acta. 1382(1):143–150.
  • Colige A, Ruggiero F, Vandenberghe I, Dubail J, Kesteloot F, Van Beeumen J, Beschin A, Brys L, Lapiere CM, Nusgens B. 2005. Domains and maturation processes that regulate the activity of ADAMTS-2, a metalloproteinase cleaving the aminopropeptide of fibrillar procollagens types I-III and V. J Biol Chem. 280(41):34397–34408.
  • Coll M, Guasch A, Aviles FX, Huber R. 1991. Three-dimensional structure of porcine procarboxypeptidase B: a structural basis of its inactivity. EMBO J. 10(1):1–9.
  • Colussi PA, Harvey NL, Kumar S. 1998a. Prodomain-dependent nuclear localization of the caspase-2 (Nedd2) precursor. A novel function for a caspase prodomain. J Biol Chem. 273(38):24535–24542.
  • Colussi PA, Harvey NL, Shearwin-Whyatt LM, Kumar S. 1998b. Conversion of procaspase-3 to an autoactivating caspase by fusion to the caspase-2 prodomain. J Biol Chem. 273(41):26566–26570.
  • Cominelli A, Halbout M, N'Kuli F, Lemoine P, Courtoy PJ, Marbaix E, Tyteca D, Henriet P. 2014. A unique C-terminal domain allows retention of matrix metalloproteinase-27 in the endoplasmic reticulum. Traffic. 15(4):401–417.
  • Conner GE. 1992. The role of the cathepsin D propeptide in sorting to the lysosome. J Biol Chem. 267(30):21738–21745.
  • Conus S, Perozzo R, Reinheckel T, Peters C, Scapozza L, Yousefi S, Simon HU. 2008. Caspase-8 is activated by cathepsin D initiating neutrophil apoptosis during the resolution of inflammation. J Exp Med. 205(3):685–698.
  • Corydon TJ, Wilsbech M, Jespersgaard C, Andresen BS, Borglum AD, Pedersen S, Bolund L, Gregersen N, Bross P. 2000. Human and mouse mitochondrial orthologs of bacterial ClpX. Incorporating Mouse Genome. 11(10):899–905.
  • Coulombe R, Grochulski P, Sivaraman J, Menard R, Mort JS, Cygler M. 1996. Structure of human procathepsin L reveals the molecular basis of inhibition by the prosegment. EMBO J. 15(20):5492–5503.
  • Coulombe R, Li Y, Takebe S, Menard R, Mason P, Mort JS, Cygler M. 1996. Crystallization and preliminary X-ray diffraction studies of human procathepsin L. Proteins. 25(3):398–400.
  • Cowling V, Downward J. 2002. Caspase-6 is the direct activator of caspase-8 in the cytochrome c-induced apoptosis pathway: absolute requirement for removal of caspase-6 prodomain. Cell Death Differ. 9(10):1046–1056.
  • Crabbe T, Ioannou C, Docherty AJ. 1993. Human progelatinase A can be activated by autolysis at a rate that is concentration-dependent and enhanced by heparin bound to the C-terminal domain. Eur J Biochem. 218(2):431–438.
  • Crabbe T, Willenbrock F, Eaton D, Hynds P, Carne AF, Murphy G, Docherty AJ. 1992. Biochemical characterization of matrilysin. Activation conforms to the stepwise mechanisms proposed for other matrix metalloproteinases. Biochemistry. 31(36):8500–8507.
  • Craik CS, Largman C, Fletcher T, Roczniak S, Barr PJ, Fletterick R, Rutter WJ. 1985. Redesigning trypsin: alteration of substrate specificity. Science. 228(4697):291–297.
  • Creemers JW, Ines Dominguez D, Plets E, Serneels L, Taylor NA, Multhaup G, Craessaerts K, Annaert W, De Strooper B. 2001. Processing of beta-secretase by furin and other members of the proprotein convertase family. J Biol Chem. 276(6):4211–4217.
  • Crunkhorn S. 2012. Trial watch: PCSK9 antibody reduces LDL cholesterol. Nat Rev Drug Discov. 11(1):11.
  • Cumin F, Evin G, Fehrentz JA, Seyer R, Castro B, Menard J, Corvol P. 1985. Inhibition of human renin by synthetic peptides derived from its prosegment. J Biol Chem. 260(16):9154–9157.
  • Cuzner ML, Opdenakker G. 1999. Plasminogen activators and matrix metalloproteases, mediators of extracellular proteolysis in inflammatory demyelination of the central nervous system. J Neuroimmunol. 94(1–2):1–14.
  • Cygler M, Sivaraman J, Grochulski P, Coulombe R, Storer AC, Mort JS. 1996. Structure of rat procathepsin B: model for inhibition of cysteine protease activity by the proregion. Structure. 4(4):405–416.
  • Dahl SW, Halkier T, Lauritzen C, Dolenc I, Pedersen J, Turk V, Turk B. 2001. Human recombinant pro-dipeptidyl peptidase I (cathepsin C) can be activated by cathepsins L and S but not by autocatalytic processing. Biochemistry. 40(6):1671–1678.
  • Dahlback B, Villoutreix BO. 2005. The anticoagulant protein C pathway. FEBS Lett. 579(15):3310–3316.
  • Dancevic CM, Fraser FW, Smith AD, Stupka N, Ward AC, McCulloch DR. 2013. Biosynthesis and expression of a disintegrin-like and metalloproteinase domain with thrombospondin-1 repeats-15: a novel versican-cleaving proteoglycanase. J Biol Chem. 288(52):37267–37276.
  • D'Angelo ME, Bird PI, Peters C, Reinheckel T, Trapani JA, Sutton VR. 2010. Cathepsin H is an additional convertase of pro-granzyme B. J Biol Chem. 285(27):20514–20519.
  • Dau T, Sarker RS, Yildirim AO, Eickelberg O, Jenne DE. 2015. Autoprocessing of neutrophil elastase near its active site reduces the efficiency of natural and synthetic elastase inhibitors. Nat Commun. 6(1):6722.
  • Davis BK, Wen H, Ting JP. 2011. The inflammasome NLRs in immunity, inflammation, and associated diseases. Annu Rev Immunol. 29(1):707–735.
  • de Bruyn M, Vandooren J, Ugarte-Berzal E, Arijs I, Vermeire S, Opdenakker G. 2016. The molecular biology of matrix metalloproteinases and tissue inhibitors of metalloproteinases in inflammatory bowel diseases. Crit Rev Biochem Mol Biol. 51(5):295–358.
  • De M, Jayarapu K, Elenich L, Monaco JJ, Colbert RA, Griffin TA. 2003. Beta 2 subunit propeptides influence cooperative proteasome assembly. J Biol Chem. 278(8):6153–6159.
  • de Sagarra MR, Mayo I, Marco S, Rodriguez-Vilarino S, Oliva J, Carrascosa JL, Casta N. J. 1999. Mitochondrial localization and oligomeric structure of HClpP, the human homologue of E. coli ClpP. J Mol Biol. 292(4):819–825.
  • De Windt A, Rai M, Bernier L, Thelen K, Soini J, Lefebvre C, Chintawar S, Lavigne J, Saarinen L, Kytomaki L, et al. 2007. Gene set enrichment analysis reveals several globally affected pathways due to SKI-1/S1P inhibition in HepG2 cells. DNA Cell Biol. 26(11):765–772.
  • Dee DR, Horimoto Y, Yada RY. 2014. Conserved prosegment residues stabilize a late-stage folding transition state of pepsin independently of ground states. Plos One. 9(7):e101339.
  • Dee DR, Yada RY. 2010. The prosegment catalyzes pepsin folding to a kinetically trapped native state. Biochemistry. 49(2):365–371.
  • Demidyuk IV, Shubin AV, Gasanov EV, Kostrov SV. 2010. Propeptides as modulators of functional activity of proteases. Biomol Concepts. 1(3–4):305–322.
  • Denault JB, Salvesen GS. 2003. Human caspase-7 activity and regulation by its N-terminal peptide. J Biol Chem. 278(36):34042–34050.
  • Denmeade SR, Lovgren J, Khan SR, Lilja H, Isaacs JT. 2001. Activation of latent protease function of pro-hK2, but not pro-PSA, involves autoprocessing. Prostate. 48(2):122–126.
  • Deryugina EI, Zajac E, Juncker-Jensen A, Kupriyanova TA, Welter L, Quigley JP. 2014. Tissue-infiltrating neutrophils constitute the major in vivo source of angiogenesis-inducing MMP-9 in the tumor microenvironment. Neoplasia. 16(10):771–788.
  • Descamps FJ, Martens E, Ballaux F, Geboes K, Opdenakker G. 2004. In vivo activation of gelatinase B/MMP-9 by trypsin in acute pancreatitis is a permissive factor in streptozotocin-induced diabetes. J Pathol. 204(5):555–561.
  • Desrivieres S, Lu H, Peyri N, Soria C, Legrand Y, Menashi S. 1993. Activation of the 92 kDa type IV collagenase by tissue kallikrein. J Cell Physiol. 157(3):587–593.
  • Dickinson CD, Kelly CR, Ruf W. 1996. Identification of surface residues mediating tissue factor binding and catalytic function of the serine protease factor VIIa. Proc Natl Acad Sci USA. 93(25):14379–14384.
  • Dillon SL, Williamson DM, Elferich J, Radler D, Joshi R, Thomas G, Shinde U. 2012. Propeptides are sufficient to regulate organelle-specific pH-dependent activation of furin and proprotein convertase 1/3. J Mol Biol. 423(1):47–62.
  • Dodt J, Reichwein J. 2003. Human cathepsin H: deletion of the mini-chain switches substrate specificity from aminopeptidase to endopeptidase. Biol Chem. 384(9):1327–1332.
  • Doggrell SA, Wanstall JC. 2004. Vascular chymase: pathophysiological role and therapeutic potential of inhibition. Cardiovasc Res. 61(4):653–662.
  • Dolenc I, Pain R, Turk V. 2007. Presence of the propeptide on recombinant lysosomal dipeptidase controls both activation and dimerization. Biol Chem. 388(1):47–51.
  • Dong N, Fang C, Jiang Y, Zhou T, Liu M, Zhou J, Shen J, Fukuda K, Qin J, Wu Q. 2013. Corin mutation R539C from hypertensive patients impairs zymogen activation and generates an inactive alternative ectodomain fragment. J Biol Chem. 288(11):7867–7874.
  • Doostzadeh-Cizeron J, Yin S, Goodrich DW. 2000. Apoptosis induced by the nuclear death domain protein p84N5 is associated with caspase-6 and NF-kappa B activation. J Biol Chem. 275(33):25336–25341.
  • Duncan ME, Richardson JP, Murray GI, Melvin WT, Fothergill JE. 1998. Human matrix metalloproteinase-9: activation by limited trypsin treatment and generation of monoclonal antibodies specific for the activated form. Eur J Biochem. 258(1):37–43.
  • Dusterhoft S, Kunzel U, Freeman M. 2017. Rhomboid proteases in human disease: mechanisms and future prospects. Biochim Biophys Acta Mol Cell Res. 1864(11):2200–2209.
  • Eaton D, Rodriguez H, Vehar GA. 1986. Proteolytic processing of human factor VIII. Correlation of specific cleavages by thrombin, factor Xa, and activated protein C with activation and inactivation of factor VIII coagulant activity. Biochemistry. 25(2):505–512.
  • Eberstadt M, Huang B, Chen Z, Meadows RP, Ng SC, Zheng L, Lenardo MJ, Fesik SW. 1998. NMR structure and mutagenesis of the FADD (Mort1) death-effector domain. Nature. 392(6679):941–945.
  • Eckfeld C, Häußler D, Schoeps B, Hermann CD, Krüger A. 2019. Functional disparities within the TIMP family in cancer: hints from molecular divergence. Cancer Metastasis Rev. 38(3):469–481.
  • Ehrnthaller C, Ignatius A, Gebhard F, Huber-Lang M. 2011. New insights of an old defense system: structure, function, and clinical relevance of the complement system. Mol Med. 17(3–4):317–329.
  • Eigenbrot C. 2002. Structure, function, and activation of coagulation factor VII. Curr Protein Pept Sci. 3(3):287–299.
  • Elagoz A, Benjannet S, Mammarbassi A, Wickham L, Seidah NG. 2002. Biosynthesis and cellular trafficking of the convertase SKI-1/S1P: ectodomain shedding requires SKI-1 activity. J Biol Chem. 277(13):11265–11275.
  • Ellis V, Behrendt N, Dano K. 1991. Plasminogen activation by receptor-bound urokinase. A kinetic study with both cell-associated and isolated receptor. J Biol Chem. 266(19):12752–12758.
  • Ermolieff J, Loy JA, Koelsch G, Tang J. 2000. Proteolytic activation of recombinant pro-memapsin 2 (Pro-beta-secretase) studied with new fluorogenic substrates. Biochemistry. 39(51):16263–16263.
  • Essalmani R, Hamelin J, Marcinkiewicz J, Chamberland A, Mbikay M, Chretien M, Seidah NG, Prat A. 2006. Deletion of the gene encoding proprotein convertase 5/6 causes early embryonic lethality in the mouse. Mol Cell Biol. 26(1):354–361.
  • Fang KC, Raymond WW, Blount JL, Caughey GH. 1997. Dog mast cell alpha-chymase activates progelatinase B by cleaving the Phe88-Gln89 and Phe91-Glu92 bonds of the catalytic domain. J Biol Chem. 272(41):25628–25635.
  • Fang N, Zhong CQ, Liang X, Tang XF, Tang B. 2010. Improvement of extracellular production of a thermophilic subtilase expressed in Escherichia coli by random mutagenesis of its N-terminal propeptide. Appl Microbiol Biotechnol. 85(5):1473–1481.
  • Feeney B, Clark AC. 2005. Reassembly of active caspase-3 is facilitated by the propeptide. J Biol Chem. 280(48):39772–39785.
  • Fehlhammer H, Bode W, Huber R. 1977. Crystal structure of bovine trypsinogen at 1-8 A resolution. II. Crystallographic refinement, refined crystal structure and comparison with bovine trypsin. J Mol Biol. 111(4):415–438.
  • Finley EM, Kornfeld S. 1994. Subcellular localization and targeting of cathepsin E. J Biol Chem. 269(49):31259–31266.
  • Foltmann B, Jensen AL. 1982. Human progastricsin. Analysis of intermediates during activation into gastricsin and determination of the amino acid sequence of the propart. Eur J Biochem. 128(1):63–70.
  • Fortelny N, Cox JH, Kappelhoff R, Starr AE, Lange PF, Pavlidis P, Overall CM. 2014. Network analyses reveal pervasive functional regulation between proteases in the human protease web. PLoS Biol. 12(5):e1001869.
  • Fox T, de Miguel E, Mort JS, Storer AC. 1992. Potent slow-binding inhibition of cathepsin B by its propeptide. Biochemistry. 31(50):12571–12576.
  • Fridman R, Toth M, Pena D, Mobashery S. 1995. Activation of progelatinase B (MMP-9) by gelatinase A (MMP-2). Cancer Res. 55(12):2548–2555.
  • Friis S, Madsen DH, Bugge TH. 2016. Distinct developmental functions of prostasin (CAP1/PRSS8) zymogen and activated prostasin. J Biol Chem. 291(6):2577–2582.
  • Friis S, Uzzun Sales K, Godiksen S, Peters DE, Lin CY, Vogel LK, Bugge TH. 2013. A matriptase-prostasin reciprocal zymogen activation complex with unique features: prostasin as a non-enzymatic co-factor for matriptase activation. J Biol Chem. 288(26):19028–19039.
  • Fuentes-Prior P, Salvesen GS. 2004. The protein structures that shape caspase activity, specificity, activation and inhibition. Biochem J. 384(2):201–232.
  • Fugere M, Limperis PC, Beaulieu-Audy V, Gagnon F, Lavigne P, Klarskov K, Leduc R, Day R. 2002. Inhibitory potency and specificity of subtilase-like pro-protein convertase (SPC) prodomains. J Biol Chem. 277(10):7648–7656.
  • Fusek M, Vetvicka V. 1994. Mitogenic function of human procathepsin D: the role of the propeptide. Biochem J. 303 (3):775–780.
  • Gaboriaud C, Thielens NM, Gregory LA, Rossi V, Fontecilla-Camps JC, Arlaud GJ. 2004. Structure and activation of the C1 complex of complement: unraveling the puzzle. Trends Immunol. 25(7):368–373.
  • Garcia-Saez I, Reverter D, Vendrell J, Aviles FX, Coll M. 1997. The three-dimensional structure of human procarboxypeptidase A2. Deciphering the basis of the inhibition, activation and intrinsic activity of the zymogen. EMBO J. 16(23):6906–6913.
  • Garlisi CG, Zou J, Devito KE, Tian F, Zhu FX, Liu J, Shah H, Wan Y, Motasim Billah M, Egan RW, et al. 2003. Human ADAM33: protein maturation and localization. Biochem Biophys Res Commun. 301(1):35–43.
  • Ge G, Greenspan DS. 2006. Developmental roles of the BMP1/TLD metalloproteinases. Birth Defect Res C. 78(1):47–68.
  • Gelb BD, Moissoglu K, Zhang J, Martignetti JA, Bromme D, Desnick RJ. 1996. Cathepsin K: isolation and characterization of the murine cDNA and genomic sequence, the homologue of the human pycnodysostosis gene. Biochem Mol Med. 59(2):200–206.
  • Geurts N, Becker-Pauly C, Martens E, Proost P, Van den Steen PE, Stöcker W, Opdenakker G. 2012. Meprins process matrix metalloproteinase-9 (MMP-9)/gelatinase B and enhance the activation kinetics by MMP-3. FEBS Lett. 586(24):4264–4269.
  • Geurts N, Martens E, Van Aelst I, Proost P, Opdenakker G, Van den Steen PE. 2008. Beta-hematin interaction with the hemopexin domain of gelatinase B/MMP-9 provokes autocatalytic processing of the propeptide, thereby priming activation by MMP-3. Biochemistry. 47(8):2689–2699.
  • Gieselmann V, Hasilik A, von Figura K. 1985. Processing of human cathepsin D in lysosomes in vitro. J Biol Chem. 260(5):3215–3220.
  • Gisler C, Luscher D, Schatzle P, Durr S, Baici A, Galliciotti G, Reif R, Bolliger MF, Kunz B, Sonderegger P. 2013. Zymogen activation of neurotrypsin and neurotrypsin-dependent agrin cleavage on the cell surface are enhanced by glycosaminoglycans. Biochem J. 453(1):83–100.
  • Glenner GG, Cohen LA. 1960. Histochemical demonstration of a species-specific trypsin-like enzyme in mast cells. Nature. 185(4716):846–847.
  • Golabek AA, Dolzhanskaya N, Walus M, Wisniewski KE, Kida E. 2008. Prosegment of tripeptidyl peptidase I is a potent, slow-binding inhibitor of its cognate enzyme. J Biol Chem. 283(24):16497–16504.
  • Gomis-Ruth FX, Gomez-Ortiz M, Vendrell J, Ventura S, Bode W, Huber R, Aviles FX. 1997. Crystal structure of an oligomer of proteolytic zymogens: detailed conformational analysis of the bovine ternary complex and implications for their activation. J Mol Biol. 269(5):861–880.
  • Gonzales PE, Solomon A, Miller AB, Leesnitzer MA, Sagi I, Milla ME. 2004. Inhibition of the tumor necrosis factor-alpha-converting enzyme by its pro domain. J Biol Chem. 279(30):31638–31645.
  • Goulet B, Baruch A, Moon NS, Poirier M, Sansregret LL, Erickson A, Bogyo M, Nepveu A. 2004. A cathepsin L isoform that is devoid of a signal peptide localizes to the nucleus in S phase and processes the CDP/Cux transcription factor. Mol Cell. 14(2):207–219.
  • Grasso S, Neumann A, Lang IM, Etscheid M, von Kockritz-Blickwede M, Kanse SM. 2018. Interaction of factor VII activating protease (FSAP) with neutrophil extracellular traps (NETs). Thromb Res. 161:36–42.
  • Griffith MJ, Breitkreutz L, Trapp H, Briet E, Noyes CM, Lundblad RL, Roberts HR. 1985. Characterization of the clotting activities of structurally different forms of activated factor IX. Enzymatic properties of normal human factor IXa alpha, factor IXa beta, and activated factor IX Chapel Hill. J Clin Invest. 75(1):4–10.
  • Groves MR, Coulombe R, Jenkins J, Cygler M. 1998. Structural basis for specificity of papain-like cysteine protease proregions toward their cognate enzymes. Proteins. 32(4):504–514.
  • Grujic M, Braga T, Lukinius A, Eloranta ML, Knight SD, Pejler G, Abrink M. 2005. Serglycin-deficient cytotoxic T lymphocytes display defective secretory granule maturation and granzyme B storage. J Biol Chem. 280(39):33411–33418.
  • Gu Z, Kaul M, Yan B, Kridel SJ, Cui J, Strongin A, Smith JW, Liddington RC, Lipton SA. 2002. S-nitrosylation of matrix metalloproteinases: signaling pathway to neuronal cell death. Science. 297(5584):1186–1190.
  • Gu Y, Wu J, Faucheu C, Lalanne JL, Diu A, Livingston DJ, Su MS. 1995. Interleukin-1 beta converting enzyme requires oligomerization for activity of processed forms in vivo. EMBO J. 14(9):1923–1931.
  • Guay J, Falgueyret JP, Ducret A, Percival MD, Mancini JA. 2000. Potency and selectivity of inhibition of cathepsin K, L and S by their respective propeptides. Eur J Biochem. 267(20):6311–6318.
  • Guhaniyogi J, Sohar I, Das K, Stock AM, Lobel P. 2009. Crystal structure and autoactivation pathway of the precursor form of human tripeptidyl-peptidase 1, the enzyme deficient in late infantile ceroid lipofuscinosis. J Biol Chem. 284(6):3985–3997.
  • Guipponi M, Vuagniaux G, Wattenhofer M, Shibuya K, Vazquez M, Dougherty L, Scamuffa N, Guida E, Okui M, Rossier C, et al. 2002. The transmembrane serine protease (TMPRSS3) mutated in deafness DFNB8/10 activates the epithelial sodium channel (ENaC) in vitro. Hum Mol Genet. 11(23):2829–2836.
  • Gullberg U, Lindmark A, Lindgren G, Persson AM, Nilsson E, Olsson I. 1995. Carboxyl-terminal prodomain-deleted human leukocyte elastase and cathepsin G are efficiently targeted to granules and enzymatically activated in the rat basophilic/mast cell line RBL. J Biol Chem. 270(21):12912–12918.
  • Guo H, Petrin D, Zhang Y, Bergeron C, Goodyer CG, LeBlanc AC. 2006. Caspase-1 activation of caspase-6 in human apoptotic neurons. Cell Death Differ. 13(2):285–292.
  • Guo S, Skala W, Magdolen V, Brandstetter H, Goettig P. 2014. Sweetened kallikrein-related peptidases (KLKs): glycan trees as potential regulators of activation and activity. Biol Chem. 395(9):959–976.
  • Hampton EN, Knuth MW, Li J, Harris JL, Lesley SA, Spraggon G. 2007. The self-inhibited structure of full-length PCSK9 at 1.9 A reveals structural homology with resistin within the C-terminal domain. Proc. Natl. Acad. Sci. U.S.A. 104(37):14604–14609.
  • Han Z, Hendrickson EA, Bremner TA, Wyche JH. 1997. A sequential two-step mechanism for the production of the mature p17:p12 form of caspase-3 in vitro. J Biol Chem. 272(20):13432–13436.
  • Hedström L, Lin TY, Fast W. 1996. Hydrophobic interactions control zymogen activation in the trypsin family of serine proteases. Biochemistry. 35(14):4515–4523.
  • Hendriks D, Wang W, Scharpe S, Lommaert MP, van Sande M. 1990. Purification and characterization of a new arginine carboxypeptidase in human serum. Biochim Biophys Acta. 1034(1):86–92.
  • Hentze M, Hasilik A, von Figura K. 1984. Enhanced degradation of cathepsin D synthesized in the presence of the threonine analog beta-hydroxynorvaline. Arch Biochem Biophys. 230(1):375–382.
  • Hermon-Taylor J, Perrin J, Grant DA, Appleyard A, Bubel M, Magee AI. 1977. Immunofluorescent localisation of enterokinase in human small intestine. Gut. 18(4):259–265.
  • Hernandez-Barrantes S, Toth M, Bernardo MM, Yurkova M, Gervasi DC, Raz Y, Sang QA, Fridman R. 2000. Binding of active (57 kDa) membrane type 1-matrix metalloproteinase (MT1-MMP) to tissue inhibitor of metalloproteinase (TIMP)-2 regulates MT1-MMP processing and pro-MMP-2 activation. J Biol Chem. 275(16):12080–12089.
  • Herriott RM. 1938. Isolation, crystallization, and properties of swine pepsinogen. J Gen Physiol. 21(4):501–540.
  • Hirata Y, Inagaki H, Kawada T. 2010. Recombinant human progranzyme 3 expressed in Escherichia coli for analysis of its activation mechanism. Microbiol Immunol. 54(2):98–104.
  • Hofbauer B, Saluja AK, Lerch MM, Bhagat L, Bhatia M, Lee HS, Frossard JL, Adler G, Steer ML. 1998. Intra-acinar cell activation of trypsinogen during caerulein-induced pancreatitis in rats. Am J Physiol. 275(2 Pt):G352–362.
  • Hoffmann JC, Pappa A, Krammer PH, Lavrik IN. 2009. A new C-terminal cleavage product of procaspase-8, p30, defines an alternative pathway of procaspase-8 activation. Mol Cell Biol. 29(16):4431–4440.
  • Holopainen JM, Moilanen JAO, Sorsa T, Kivelä-RajamäKi M, Tervahartiala T, Vesaluoma MH, Tervo TMT. 2003. Activation of matrix metalloproteinase-8 by membrane type 1-MMP and their expression in human tears after photorefractive keratectomy. Invest Ophthalmol Vis Sci. 44(6):2550–2556.
  • Hooper JD, Clements JA, Quigley JP, Antalis TM. 2001. Type II transmembrane serine proteases. Insights into an emerging class of cell surface proteolytic enzymes. J Biol Chem. 276(2):857–860.
  • Hooper JD, Nicol DL, Dickinson JL, Eyre HJ, Scarman AL, Normyle JF, Stuttgen MA, Douglas ML, Loveland KA, Sutherland GR. 1999. Testisin, a new human serine proteinase expressed by premeiotic testicular germ cells and lost in testicular germ cell tumors. Cancer Res. 59(13):3199–3205.
  • Horn M, Doleckova-Maresova L, Rulisek L, Masa M, Vasiljeva O, Turk B, Gan-Erdene T, Baudys M, Mares M. 2005. Activation processing of cathepsin H impairs recognition by its propeptide. Biol Chem. 386(9):941–947.
  • Hou WS, Bromme D, Zhao Y, Mehler E, Dushey C, Weinstein H, Miranda CS, Fraga C, Greig F, Carey J, et al. 1999. Characterization of novel cathepsin K mutations in the pro and mature polypeptide regions causing pycnodysostosis. J Clin Invest. 103(5):731–738.
  • Howard L, Maciewicz RA, Blobel CP. 2000. Cloning and characterization of ADAM28: evidence for autocatalytic pro-domain removal and for cell surface localization of mature ADAM28. Biochem J. 348(1):21–27.
  • Hoylaerts M, Rijken DC, Lijnen HR, Collen D. 1982. Kinetics of the activation of plasminogen by human tissue plasminogen activator. Role of fibrin. J Biol Chem. 257(6):2912–2919.
  • Hu J, Fiten P, Van den Steen PE, Chaltin P, Opdenakker G. 2005a. Simulation of evolution-selected propeptide by high-throughput selection of a peptidomimetic inhibitor on a capillary DNA sequencer platform. Anal Chem. 77(7):2116–2124.
  • Hu J, Van den Steen PE, Dillen C, Opdenakker G. 2005b. Targeting neutrophil collagenase/matrix metalloproteinase-8 and gelatinase B/matrix metalloproteinase-9 with a peptidomimetic inhibitor protects against endotoxin shock. Biochem Pharmacol. 70(4):535–544.
  • Hu J, Van den Steen PE, Sang QX, Opdenakker G. 2007. Matrix metalloproteinase inhibitors as therapy for inflammatory and vascular diseases. Nat Rev Drug Discov. 6(6):480–498.
  • Hu Q, Wu D, Chen W, Yan Z, Yan C, He T, Liang Q, Shi Y. 2014. Molecular determinants of caspase-9 activation by the Apaf-1 apoptosome. Proc Natl Acad Sci USA. 111(46):16254–16261.
  • Huang C, Li L, Krilis SA, Chanasyk K, Tang Y, Li Z, Hunt JE, Stevens RL. 1999. Human tryptases alpha and beta/II are functionally distinct due, in part, to a single amino acid difference in one of the surface loops that forms the substrate-binding cleft. J Biol Chem. 274(28):19670–19676.
  • Huber EM, Heinemeyer W, Li X, Arendt CS, Hochstrasser M, Groll M. 2016. A unified mechanism for proteolysis and autocatalytic activation in the 20S proteasome. Nat Commun. 7(1):10900.
  • Hubmacher D, Schneider M, Berardinelli SJ, Takeuchi H, Willard B, Reinhardt DP, Haltiwanger RS, Apte SS. 2017. Unusual life cycle and impact on microfibril assembly of ADAMTS17, a secreted metalloprotease mutated in genetic eye disease. Sci Rep. 7:41871
  • Huete-Perez JA, Engel JC, Brinen LS, Mottram JC, McKerrow JH. 1999. Protease trafficking in two primitive eukaryotes is mediated by a prodomain protein motif. J Biol Chem. 274(23):16249–16256.
  • Hughes MA, Harper N, Butterworth M, Cain K, Cohen GM, MacFarlane M. 2009. Reconstitution of the death-inducing signaling complex reveals a substrate switch that determines CD95-mediated death or survival. Mol Cell. 35(3):265–279.
  • Illman SA, Keski-Oja J, Parks WC, Lohi J. 2003. The mouse matrix metalloproteinase, epilysin (MMP-28), is alternatively spliced and processed by a furin-like proprotein convertase. Biochem J. 375(1):191–197.
  • Inouye K, Fruton JS. 1967. Studies on the specificity of pepsin. Biochemistry. 6(6):1765–1777.
  • Itoh Y, Kajita M, Kinoh H, Mori H, Okada A, Seiki M. 1999. Membrane type 4 matrix metalloproteinase (MT4-MMP, MMP-17) is a glycosylphosphatidylinositol-anchored proteinase. J Biol Chem. 274(48):34260–34266.
  • Itoh Y, Takamura A, Ito N, Maru Y, Sato H, Suenaga N, Aoki T, Seiki M. 2001. Homophilic complex formation of MT1-MMP facilitates proMMP-2 activation on the cell surface and promotes tumor cell invasion. EMBO J. 20(17):4782–4793.
  • Jackson PL, Xu X, Wilson L, Weathington NM, Clancy JP, Blalock JE, Gaggar A. 2010. Human neutrophil elastase-mediated cleavage sites of MMP-9 and TIMP-1: implications to cystic fibrosis proteolytic dysfunction. Mol Med. 16(5–6):159–166.
  • Jasuja R, Ge G, Voss NG, Lyman-Gingerich J, Branam AM, Pelegri FJ, Greenspan DS. 2007. Bone morphogenetic protein 1 prodomain specifically binds and regulates signaling by bone morphogenetic proteins 2 and 4. J Biol Chem. 282(12):9053–9062.
  • Jerala R, Zerovnik E, Kidric J, Turk V. 1998. pH-induced conformational transitions of the propeptide of human cathepsin L. A role for a molten globule state in zymogen activation. J Biol Chem. 273(19):11498–11504.
  • Jiang J, Yang J, Feng P, Zuo B, Dong N, Wu Q, He Y. 2014. N-glycosylation is required for matriptase-2 autoactivation and ectodomain shedding. J Biol Chem. 289(28):19500–19507.
  • Jin X, Hirosaki T, Lin CY, Dickson RB, Higashi S, Kitamura H, Miyazaki K. 2005. Production of soluble matriptase by human cancer cell lines and cell surface activation of its zymogen by trypsin. J Cell Biochem. 95(3):632–647.
  • Jin X, Yagi M, Akiyama N, Hirosaki T, Higashi S, Lin CY, Dickson RB, Kitamura H, Miyazaki K. 2006. Matriptase activates stromelysin (MMP-3) and promotes tumor growth and angiogenesis. Cancer Sci. 97(12):1327–1334.
  • Jing H, Macon KJ, Moore D, DeLucas LJ, Volanakis JE, Narayana SV. 1999. Structural basis of profactor D activation: from a highly flexible zymogen to a novel self-inhibited serine protease, complement factor D. EMBO J. 18(4):804–814.
  • Johnson GD, Hersh LB. 1994. Expression of meprin subunit precursors. Membrane anchoring through the beta subunit and mechanism of zymogen activation. J Biol Chem. 269(10):7682–7688.
  • Jozic D, Bourenkov G, Lim NH, Visse R, Nagase H, Bode W, Maskos K. 2005. X-ray structure of human proMMP-1: new insights into procollagenase activation and collagen binding. J Biol Chem. 280(10):9578–9585.
  • Jutras I, Reudelhuber TL. 1999. Prorenin processing by cathepsin B in vitro and in transfected cells. FEBS Lett. 443(1):48–52.
  • Kageyama T, Tatematsu M, Ichinose M, Yahagi N, Miki K, Moriyama A, Yonezawa S. 1998. Development-dependent expression of cathepsins d and e in various rat tissues, with special reference to the high expression of cathepsin e in fetal liver. Zoolog Sci. 15(4):517–523.
  • Kang T, Nagase H, Pei D. 2002c. Activation of membrane-type matrix metalloproteinase 3 zymogen by the proprotein convertase furin in the trans-Golgi network. Cancer Res. 62(3):675–681.
  • Kang TB, Oh GS, Scandella E, Bolinger B, Ludewig B, Kovalenko A, Wallach D. 2008. Mutation of a self-processing site in caspase-8 compromises its apoptotic but not its nonapoptotic functions in bacterial artificial chromosome-transgenic mice. J Immunol. 181(4):2522–2532.
  • Kang SG, Ortega J, Singh SK, Wang N, Huang NN, Steven AC, Maurizi MR. 2002a. Functional proteolytic complexes of the human mitochondrial ATP-dependent protease, hClpXP. J Biol Chem. 277(23):21095–21102.
  • Kang T, Zhao YG, Pei D, Sucic JF, Sang QX. 2002b. Intracellular activation of human adamalysin 19/disintegrin and metalloproteinase 19 by furin occurs via one of the two consecutive recognition sites. J Biol Chem. 277(28):25583–25591.
  • Kannemeier C, Feussner A, Stohr HA, Weisse J, Preissner KT, Romisch J. 2001. Factor VII and single-chain plasminogen activator-activating protease: activation and autoactivation of the proenzyme. Eur J Biochem. 268(13):3789–3796.
  • Karmilin K, Schmitz C, Kuske M, Korschgen H, Olf M, Meyer K, Hildebrand A, Felten M, Fridrich S, Yiallouros I, et al. 2019. Mammalian plasma fetuin-B is a selective inhibitor of ovastacin and meprin metalloproteinases. Sci Rep. 9(1):546.
  • Karrer KM, Peiffer SL, DiTomas ME. 1993. Two distinct gene subfamilies within the family of cysteine protease genes. Proc Natl Acad Sci U S A. 90(7):3063–3067.
  • Kawano N, Kang W, Yamashita M, Koga Y, Yamazaki T, Hata T, Miyado K, Baba T. 2010. Mice lacking two sperm serine proteases, ACR and PRSS21, are subfertile, but the mutant sperm are infertile in vitro. Biol Reprod. 83(3):359–369.
  • Kazama Y, Hamamoto T, Foster DC, Kisiel W. 1995. Hepsin, a putative membrane-associated serine protease, activates human factor VII and initiates a pathway of blood coagulation on the cell surface leading to thrombin formation. J Biol Chem. 270(1):66–72.
  • Kelwick R, Desanlis I, Wheeler GN, Edwards DR. 2015. The ADAMTS (A Disintegrin and Metalloproteinase with Thrombospondin motifs) family. Genome Biol. 16(1):113.
  • Khan AR, James MN. 1998. Molecular mechanisms for the conversion of zymogens to active proteolytic enzymes. Protein Sci. 7(4):815–836.
  • Kikkawa Y, Yamanaka N, Tada J, Kanamori N, Tsumura K, Hosoi K. 1998. Prorenin processing and restricted endoproteolysis by mouse tissue kallikrein family enzymes (mK1, mK9, mK13, and mK22). Biochim Biophys Acta. 1382(1):55–64.
  • Kim DR, Sharmin S, Inoue M, Kido H. 2001. Cloning and expression of novel mosaic serine proteases with and without a transmembrane domain from human lung. Biochim Biophys Acta. 1518(1–2):204–209.
  • Kirschke H, Barrett AJ, Rawlings ND. 1995. Proteinases 1: lysosomal cysteine proteinases. Protein Profile. 2(14):1581–1643.
  • Kischkel FC, Lawrence DA, Tinel A, LeBlanc H, Virmani A, Schow P, Gazdar A, Blenis J, Arnott D, Ashkenazi A. 2001. Death receptor recruitment of endogenous caspase-10 and apoptosis initiation in the absence of caspase-8. J Biol Chem. 276(49):46639–46646.
  • Kishore U, Reid KB. 2000. C1q: structure, function, and receptors. Immunopharmacology. 49(1–2):159–170.
  • Kiyomiya K, Lee MS, Tseng IC, Zuo H, Barndt RJ, Johnson MD, Dickson RB, Lin CY. 2006. Matriptase activation and shedding with HAI-1 is induced by steroid sex hormones in human prostate cancer cells, but not in breast cancer cells. Am J Physiol Cell Physiol. 291(1):C40–49.
  • Klaiman G, Champagne N, LeBlanc AC. 2009. Self-activation of Caspase-6 in vitro and in vivo: Caspase-6 activation does not induce cell death in HEK293T cells. Biochim Biophys Acta. 1793(3):592–601.
  • Knappe S, Wu F, Masikat MR, Morser J, Wu Q. 2003. Functional analysis of the transmembrane domain and activation cleavage of human corin: design and characterization of a soluble corin. J Biol Chem. 278(52):52363–52370.
  • Knäuper V, Murphy G, Tschesche H. 1996. Activation of human neutrophil procollagenase by stromelysin 2. Eur J Biochem. 235(1–2):187–191.
  • Knäuper V, Smith B, Lopez-Otin C, Murphy G. 1997. Activation of progelatinase B (proMMP-9) by active collagenase-3 (MMP-13). Eur J Biochem. 248(2):369–373.
  • Knäuper V, Will H, Lopez-Otin C, Smith B, Atkinson SJ, Stanton H, Hembry RM, Murphy G. 1996. Cellular mechanisms for human procollagenase-3 (MMP-13) activation. Evidence that MT1-MMP (MMP-14) and gelatinase a (MMP-2) are able to generate active enzyme. J Biol Chem. 271(29):17124–17131.
  • Koga H, Mori N, Yamada H, Nishimura Y, Tokuda K, Kato K, Omoto T. 1992. Endo- and aminopeptidase activities of rat cathepsin H. Chem Pharm Bull. 40(4):965–970.
  • Koo BH, Apte SS. 2010. Cell-surface processing of the metalloprotease pro-ADAMTS9 is influenced by the chaperone GRP94/gp96. J Biol Chem. 285(1):197–205.
  • Koo BH, Longpre JM, Somerville RP, Alexander JP, Leduc R, Apte SS. 2006. Cell-surface processing of pro-ADAMTS9 by furin. J Biol Chem. 281(18):12485–12494.
  • Koo BH, Longpre JM, Somerville RP, Alexander JP, Leduc R, Apte SS. 2007. Regulation of ADAMTS9 secretion and enzymatic activity by its propeptide. J Biol Chem. 282(22):16146–16154.
  • Kopitz J, Arnold A, Meissner T, Cantz M. 1993. Protein catabolism in fibroblasts cultured from patients with mucolipidosis II and other lysosomal disorders. Biochem J. 295(2):577–580.
  • Koppen M, Bonn F, Ehses S, Langer T. 2009. Autocatalytic processing of m-AAA protease subunits in mitochondria. MBoC. 20(19):4216–4224.
  • Korschgen H, Kuske M, Karmilin K, Yiallouros I, Balbach M, Floehr J, Wachten D, Jahnen-Dechent W, Stöcker W. 2017. Intracellular activation of ovastacin mediates pre-fertilization hardening of the zona pellucida. Mol Hum Reprod. 23(9):607–616.
  • Koshikawa N, Yasumitsu H, Nagashima Y, Umeda M, Miyazaki K. 1994. Identification of one- and two-chain forms of trypsinogen 1 produced by a human gastric adenocarcinoma cell line. Biochem J. 303 (1):187–190.
  • Krahenbuhl O, Rey C, Jenne D, Lanzavecchia A, Groscurth P, Carrel S, Tschopp J. 1988. Characterization of granzymes A and B isolated from granules of cloned human cytotoxic T lymphocytes. J Immunol. 141(10):3471–3477.
  • Kraut J, High DF, Sieker LC. 1964. Chymotrypsinogen: increased resolution and absolute configuration. Proc Natl Acad Sci U S A. 51(5):839–845.
  • Krüger A, Kates RE, Edwards DR. 2010. Avoiding spam in the proteolytic internet: future strategies for anti-metastatic MMP inhibition. Biochim Biophys Acta. 1803(1):95–102.
  • Kucharewicz I, Kowal K, Buczko W, Bodzenta-Łukaszyk A. 2003. The plasmin system in airway remodeling. Thromb Res. 112(1–2):1–7.
  • Kunitz M, Northrop JH. 1935. Crystalline chymo-trypsin and chymo-trypsinogen: I. Isolation, crystallization, and general properties of a new proteolytic enzyme and its precursor. J Gen Physiol. 18(4):433–458.
  • Kutz WE, Wang LW, Bader HL, Majors AK, Iwata K, Traboulsi EI, Sakai LY, Keene DR, Apte SS. 2011. ADAMTS10 protein interacts with fibrillin-1 and promotes its deposition in extracellular matrix of cultured fibroblasts. J Biol Chem. 286(19):17156–17167.
  • Kwaan HC, McMahon B. 2009. The role of plasminogen-plasmin system in cancer. Cancer Treat Res. 148:43–66.
  • Kwon HJ, Lagace TA, McNutt MC, Horton JD, Deisenhofer J. 2008. Molecular basis for LDL receptor recognition by PCSK9. Proc Natl Acad Sci USA. 105(6):1820–1825.
  • Lamkanfi M, Kanneganti TD, Van Damme P, Vanden Berghe T, Vanoverberghe I, Vandekerckhove J, Vandenabeele P, Gevaert K, Nunez G. 2008. Targeted peptidecentric proteomics reveals caspase-7 as a substrate of the caspase-1 inflammasomes. Mol Cell Proteomics. 7(12):2350–2363.
  • Langer T, Kaser M, Klanner C, Leonhard K. 2001. AAA proteases of mitochondria: quality control of membrane proteins and regulatory functions during mitochondrial biogenesis. Biochem Soc Trans. 29(4):431–436.
  • Laurent-Matha V, Derocq D, Prebois C, Katunuma N, Liaudet-Coopman E. 2006. Processing of human cathepsin D is independent of its catalytic function and auto-activation: involvement of cathepsins L and B. J Biochem. 139(3):363–371.
  • Laursen LS, Overgaard MT, Soe R, Boldt HB, Sottrup-Jensen L, Giudice LC, Conover CA, Oxvig C. 2001. Pregnancy-associated plasma protein-A (PAPP-A) cleaves insulin-like growth factor binding protein (IGFBP)-5 independent of IGF: implications for the mechanism of IGFBP-4 proteolysis by PAPP-A. FEBS Lett. 504(1–2):36–40.
  • Lawson JH, Mann KG. 1991. Cooperative activation of human factor IX by the human extrinsic pathway of blood coagulation. J Biol Chem. 266(17):11317–11327.
  • LeBlanc A, Liu H, Goodyer C, Bergeron C, Hammond J. 1999. Caspase-6 role in apoptosis of human neurons, amyloidogenesis, and Alzheimer's disease. J Biol Chem. 274(33):23426–23436.
  • Lechner AM, Assfalg-Machleidt I, Zahler S, Stoeckelhuber M, Machleidt W, Jochum M, Nagler DK. 2006. RGD-dependent binding of procathepsin X to integrin alphavbeta3 mediates cell-adhesive properties. J Biol Chem. 281(51):39588–39597.
  • Leduc R, Molloy SS, Thorne BA, Thomas G. 1992. Activation of human furin precursor processing endoprotease occurs by an intramolecular autoproteolytic cleavage. J Biol Chem. 267(20):14304–14308.
  • Lee MS, Kiyomiya K, Benaud C, Dickson RB, Lin CY. 2005. Simultaneous activation and hepatocyte growth factor activator inhibitor 1-mediated inhibition of matriptase induced at activation foci in human mammary epithelial cells. Am J Physiol Cell Physiol. 288(4):C932–941.
  • Lei X, Li YM. 2009. The processing of human rhomboid intramembrane serine protease RHBDL2 is required for its proteolytic activity. J Mol Biol. 394(5):815–825.
  • Leighton M, Kadler KE. 2003. Paired basic/Furin-like proprotein convertase cleavage of Pro-BMP-1 in the trans-Golgi network. J Biol Chem. 278(20):18478–18484.
  • Lenting PJ, ter Maat H, Clijsters PP, Donath MJ, van Mourik JA, Mertens K. 1995. Cleavage at arginine 145 in human blood coagulation factor IX converts the zymogen into a factor VIII binding enzyme. J Biol Chem. 270(25):14884–14890.
  • Lesavre PH, Müller-Eberhard HJ. 1978. Mechanism of action of factor D of the alternative complement pathway. J Exp Med. 148(6):1498–1509.
  • Levitin F, Stern O, Weiss M, Gil-Henn C, Ziv R, Prokocimer Z, Smorodinsky NI, Rubinstein DB, Wreschner DH. 2005. The MUC1 SEA module is a self-cleaving domain. J Biol Chem. 280(39):33374–33386.
  • Leyvraz C, Charles RP, Rubera I, Guitard M, Rotman S, Breiden B, Sandhoff K, Hummler E. 2005. The epidermal barrier function is dependent on the serine protease CAP1/Prss8. J Cell Biol. 170(3):487–496.
  • Li Z, Kienetz M, Cherney MM, James MN, Bromme D. 2008. The crystal and molecular structures of a cathepsin K:chondroitin sulfate complex. J Mol Biol. 383(1):78–91.
  • Li M, Nakayama K, Shuto Y, Somogyvari-Vigh A, Arimura A. 1998. Testis-specific prohormone convertase PC4 processes the precursor of pituitary adenylate cyclase-activating polypeptide (PACAP). Peptides. 19(2):259–268.
  • Li P, Nijhawan D, Budihardjo I, Srinivasula SM, Ahmad M, Alnemri ES, Wang X. 1997. Cytochrome c and dATP-dependent formation of Apaf-1/caspase-9 complex initiates an apoptotic protease cascade. Cell. 91(4):479–489.
  • Liao X, Wang W, Chen S, Wu Q. 2007. Role of glycosylation in corin zymogen activation. J Biol Chem. 282(38):27728–27735.
  • Ligtenberg MJ, Kruijshaar L, Buijs F, van Meijer M, Litvinov SV, Hilkens J. 1992. Cell-associated episialin is a complex containing two proteins derived from a common precursor. J Biol Chem. 267(9):6171–6177.
  • Lin L, Sohar I, Lackland H, Lobel P. 2001. The human CLN2 protein/tripeptidyl-peptidase I is a serine protease that autoactivates at acidic pH. J Biol Chem. 276(3):2249–2255.
  • Lindmark A, Persson AM, Olsson I. 1990. Biosynthesis and processing of cathepsin G and neutrophil elastase in the leukemic myeloid cell line U-937. Blood. 76(11):2374–2380.
  • Linnevers C, Smeekens SP, Bromme D. 1997. Human cathepsin W, a putative cysteine protease predominantly expressed in CD8+ T-lymphocytes. FEBS Lett. 405(3):253–259.
  • Loechel F, Overgaard MT, Oxvig C, Albrechtsen R, Wewer UM. 1999. Regulation of human ADAM 12 protease by the prodomain. Evidence for a functional cysteine switch. J Biol Chem. 274(19):13427–13433.
  • Longpre JM, McCulloch DR, Koo BH, Alexander JP, Apte SS, Leduc R. 2009. Characterization of proADAMTS5 processing by proprotein convertases. Int J Biochem Cell Biol. 41(5):1116–1126.
  • Lopez de Cicco R, Bassi DE, Zucker S, Seidah NG, Klein-Szanto AJ. 2005. Human carcinoma cell growth and invasiveness is impaired by the propeptide of the ubiquitous proprotein convertase furin. Cancer Res. 65(10):4162–4171.
  • Lovgren J, Rajakoski K, Karp M, Lundwall a, Lilja H. 1997. Activation of the zymogen form of prostate-specific antigen by human glandular kallikrein 2. Biochem Biophys Res Commun. 238(2):549–555.
  • Lu D, Yuan X, Zheng X, Sadler JE. 1997. Bovine proenteropeptidase is activated by trypsin, and the specificity of enteropeptidase depends on the heavy chain. J Biol Chem. 272(50):31293–31300.
  • Lum L, Reid MS, Blobel CP. 1998. Intracellular maturation of the mouse metalloprotease disintegrin MDC15. J Biol Chem. 273(40):26236–26247.
  • Lyons PJ, Callaway MB, Fricker LD. 2008. Characterization of carboxypeptidase A6, an extracellular matrix peptidase. J Biol Chem. 283(11):7054–7063.
  • Mach L, Mort JS, Glossl J. 1994. Maturation of human procathepsin B. Proenzyme activation and proteolytic processing of the precursor to the mature proteinase, in vitro, are primarily unimolecular processes. J Biol Chem. 269(17):13030–13035.
  • Magarinos NJ, Bryant KJ, Fosang AJ, Adachi R, Stevens RL, McNeil HP. 2013. Mast cell-restricted, tetramer-forming tryptases induce aggrecanolysis in articular cartilage by activating matrix metalloproteinase-3 and -13 zymogens. JI. 191(3):1404–1412.
  • Majerus EM, Zheng X, Tuley EA, Sadler JE. 2003. Cleavage of the ADAMTS13 propeptide is not required for protease activity. J Biol Chem. 278(47):46643–46648.
  • Malladi S, Challa-Malladi M, Fearnhead HO, Bratton SB. 2009. The Apaf-1*procaspase-9 apoptosome complex functions as a proteolytic-based molecular timer. EMBO J. 28(13):1916–1925.
  • Mallen-St Clair J, Shi GP, Sutherland RE, Chapman HA, Caughey GH, Wolters PJ. 2006. Cathepsins L and S are not required for activation of dipeptidyl peptidase I (cathepsin C) in mice. Biol Chem. 387(8):1143–1146.
  • Malm J, Hellman J, Hogg P, Lilja H. 2000. Enzymatic action of prostate-specific antigen (PSA or hK3): substrate specificity and regulation by Zn(2+), a tight-binding inhibitor. Prostate. 45(2):132–139.
  • Marchenko ND, Marchenko GN, Strongin AY. 2002. Unconventional activation mechanisms of MMP-26, a human matrix metalloproteinase with a unique PHCGXXD cysteine-switch motif. J Biol Chem. 277(21):18967–18972.
  • Martin SJ, Amarante-Mendes GP, Shi L, Chuang TH, Casiano CA, O'Brien GA, Fitzgerald P, Tan EM, Bokoch GM, Greenberg AH, et al. 1996. The cytotoxic cell protease granzyme B initiates apoptosis in a cell-free system by proteolytic processing and activation of the ICE/CED-3 family protease, CPP32, via a novel two-step mechanism. EMBO J. 15(10):2407–2416.
  • Martinon F, Burns K, Tschopp J. 2002. The inflammasome: a molecular platform triggering activation of inflammatory caspases and processing of proIL-beta. Mol Cell. 10(2):417–426.
  • Martins LM, Turk BE, Cowling V, Borg A, Jarrell ET, Cantley LC, Downward J. 2003. Binding specificity and regulation of the serine protease and PDZ domains of HtrA2/Omi. J Biol Chem. 278(49):49417–49427.
  • Masson E, Chen JM, Scotet V, Le MC, Ferec C. 2008. Association of rare chymotrypsinogen C (CTRC) gene variations in patients with idiopathic chronic pancreatitis. Hum Genet. 123(1):83–91.
  • Masson D, Tschopp J. 1987. A family of serine esterases in lytic granules of cytolytic T lymphocytes. Cell. 49(5):679–685.
  • Matsumoto-Miyai K, Sokolowska E, Zurlinden A, Gee CE, Luscher D, Hettwer S, Wolfel J, Ladner AP, Ster J, Gerber U, et al. 2009. Coincident pre- and postsynaptic activation induces dendritic filopodia via neurotrypsin-dependent agrin cleavage. Cell. 136(6):1161–1171.
  • Maubach G, Schilling K, Rommerskirch W, Wenz I, Schultz JE, Weber E, Wiederanders B. 1997. The inhibition of cathepsin S by its propeptide-specificity and mechanism of action. Eur J Biochem. 250(3):745–750.
  • Maxwell KN, Breslow JL. 2004. Adenoviral-mediated expression of Pcsk9 in mice results in a low-density lipoprotein receptor knockout phenotype. Proc Natl Acad Sci U S A. 101(18):7100–7105.
  • Mayer G, Hamelin J, Asselin MC, Pasquato A, Marcinkiewicz E, Tang M, Tabibzadeh S, Seidah NG. 2008. The regulated cell surface zymogen activation of the proprotein convertase PC5A directs the processing of its secretory substrates. J Biol Chem. 283(4):2373–2384.
  • Mayne J, Dewpura T, Raymond A, Bernier L, Cousins M, Ooi TC, Davignon J, Seidah NG, Mbikay M, Chretien M. 2011. Novel loss-of-function PCSK9 variant is associated with low plasma LDL cholesterol in a French-Canadian family and with impaired processing and secretion in cell culture. Clin Chem. 57(10):1415–1423.
  • Mbikay M, Seidah NG, Chretien M. 2001. Neuroendocrine secretory protein 7B2: structure, expression and functions. Biochem J. 357(Pt 2):329–342.
  • Mbikay M, Tadros H, Ishida N, Lerner CP, De Lamirande E, Chen A, El-Alfy M, Clermont Y, Seidah NG, Chretien M, et al. 1997. Impaired fertility in mice deficient for the testicular germ-cell protease PC4. Proc Natl Acad Sci U S A. 94(13):6842–6846.
  • McEuen AR, Sharma B, Walls AF. 1995. Regulation of the activity of human chymase during storage and release from mast cells: the contributions of inorganic cations, pH, heparin and histamine. Biochim Biophys Acta. 1267(2–3):115–121.
  • McIlwain DR, Berger T, Mak TW. 2013. Caspase functions in cell death and disease. Cold Spring Harb Perspect Biol. 5(4):a008656–a008656.
  • McIntyre GF, Godbold GD, Erickson AH. 1994. The pH-dependent membrane association of procathepsin L is mediated by a 9-residue sequence within the propeptide. J Biol Chem. 269(1):567–572.
  • McNutt MC, Lagace TA, Horton JD. 2007. Catalytic activity is not required for secreted PCSK9 to reduce low density lipoprotein receptors in HepG2 cells. J Biol Chem. 282(29):20799–20803.
  • McQueney MS, Amegadzie BY, D’Alessio K, Hanning CR, McLaughlin MM, McNulty D, Carr SA, Ijames C, Kurdyla J, Jones CS. 1997. Autocatalytic activation of human cathepsin K. J Biol Chem. 272(21):13955–13960.
  • Medema JP, Scaffidi C, Kischkel FC, Shevchenko A, Mann M, Krammer PH, Peter ME. 1997. FLICE is activated by association with the CD95 death-inducing signaling complex (DISC). EMBO J. 16(10):2794–2804.
  • Meergans T, Hildebrandt AK, Horak D, Haenisch C, Wendel A. 2000. The short prodomain influences caspase-3 activation in HeLa cells. Biochem J. 349(1):135–140.
  • Mikolajczyk J, Scott FL, Krajewski S, Sutherlin DP, Salvesen GS. 2004. Activation and substrate specificity of caspase-14. Biochemistry. 43(32):10560–10569.
  • Milla ME, Leesnitzer MA, Moss ML, Clay WC, Carter HL, Miller AB, Su JL, Lambert MH, Willard DH, Sheeley DM, et al. 1999. Specific sequence elements are required for the expression of functional tumor necrosis factor-alpha-converting enzyme (TACE). J Biol Chem. 274(43):30563–30570.
  • Miller JS, Westin EH, Schwartz LB. 1989. Cloning and characterization of complementary DNA for human tryptase. J Clin Invest. 84(4):1188–1195.
  • Min HJ, Lee MK, Lee JW, Kim S. 2014. TMPRSS4 induces cancer cell invasion through pro-uPA processing. Biochem Biophys Res Commun. 446(1):1–7.
  • Mirandola L, J. Cannon M, Cobos E, Bernardini G, Jenkins MR, Kast WM, Chiriva-Internati M. 2011. Cancer testis antigens: novel biomarkers and targetable proteins for ovarian cancer. Int Rev Immunol. 30(2–3):127–137.
  • Miyazawa K. 2010. Hepatocyte growth factor activator (HGFA): a serine protease that links tissue injury to activation of hepatocyte growth factor. FEBS J. 277(10):2208–2214.
  • Mole SE, Williams RE, Williams RE. 1993. [published online, updated 2013] Neuronal ceroid-lipofuscinoses. Seattle (WA): University of Washington Press.
  • Monkovic DD, Tracy PB. 1990. Activation of human factor V by factor Xa and thrombin. Biochemistry. 29(5):1118–1128.
  • Morgunova E, Tuuttila A, Bergmann U, Isupov M, Lindqvist Y, Schneider G, Tryggvason K. 1999. Structure of human pro-matrix metalloproteinase-2: activation mechanism revealed. Science. 284(5420):1667–1670.
  • Mort JS, Buttle DJ. 1997. Cathepsin B. Int J Biochem Cell Biol. 29(5):715–720.
  • Moss ML, Bomar M, Liu Q, Sage H, Dempsey P, Lenhart PM, Gillispie PA, Stoeck A, Wildeboer D, Bartsch JW, Palmisano R, et al. 2007. The ADAM10 prodomain is a specific inhibitor of ADAM10 proteolytic activity and inhibits cellular shedding events. J Biol Chem. 282(49):35712–35721.
  • Moss ML, Jin SL, Milla ME, Bickett DM, Burkhart W, Carter HL, Chen WJ, Clay WC, Didsbury JR, Hassler D, Hoffman C, et al. 1997. Cloning of a disintegrin metalloproteinase that processes precursor tumour-necrosis factor-alpha. Nature. 385(6618):733–736.
  • Moulard M, Michon T, Kerfelec B, Chapus C. 1990. Further studies on the human pancreatic binary complexes involving procarboxypeptidase A. FEBS Lett. 261(1):179–183.
  • Muller L, Cameron A, Fortenberry Y, Apletalina EV, Lindberg I. 2000. Processing and sorting of the prohormone convertase 2 propeptide. J Biol Chem. 275(50):39213–39222.
  • Muntener K, Willimann A, Zwicky R, Svoboda B, Mach L, Baici A. 2005. Folding competence of N-terminally truncated forms of human procathepsin B. J Biol Chem. 280(12):11973–11980.
  • Muntener K, Zwicky R, Csucs G, Baici A. 2003. The alternative use of exons 2 and 3 in cathepsin B mRNA controls enzyme trafficking and triggers nuclear fragmentation in human cells. Histochem Cell Biol. 119(2):93–101.
  • Muntener K, Zwicky R, Csucs G, Rohrer J, Baici A. 2004. Exon skipping of cathepsin B: mitochondrial targeting of a lysosomal peptidase provokes cell death. J Biol Chem. 279(39):41012–41017.
  • Murakami K, Inagami T. 1975. Isolation of pure and stable renin from hog kidney. Biochem Biophys Res Commun. 62(3):757–763.
  • Murakami M, Karnik SS, Husain A. 1995. Human prochymase activation. A novel role for heparin in zymogen processing. J Biol Chem. 270(5):2218–2223.
  • Murakami K, Takahashi S, Hirose S, Takii Y, Inagami T. 1980. Renin precursor and its activation mechanism in hog kidney. Clin Sci (Lond). 59(s6):21s–24s.
  • Nagase H, Visse R, Murphy G. 2006. Structure and function of matrix metalloproteinases and TIMPs. Cardiovasc Res. 69(3):562–573.
  • Nagler DK, Menard R. 1998. Human cathepsin X: a novel cysteine protease of the papain family with a very short proregion and unique insertions. FEBS Lett. 434(1–2):135–139.
  • Nakamura H, Fujii Y, Ohuchi E, Yamamoto E, Okada Y. 1998. Activation of the precursor of human stromelysin 2 and its interactions with other matrix metalloproteinases. Eur J Biochem. 253(1):67–75.
  • Nakayama K, Kim WS, Torii S, Hosaka M, Nakagawa T, Ikemizu J, Baba T, Murakami K. 1992. Identification of the fourth member of the mammalian endoprotease family homologous to the yeast Kex2 protease. Its testis-specific expression. J Biol Chem. 267(9):5897–5900.
  • Naudin C, Burillo E, Blankenberg S, Butler L, Renne T. 2017. Factor XII Contact Activation. Semin Thromb Hemost. 43(08):814–826.
  • Nemoda Z, Sahin-Toth M. 2005. The tetra-aspartate motif in the activation peptide of human cationic trypsinogen is essential for autoactivation control but not for enteropeptidase recognition. J Biol Chem. 280(33):29645–29652.
  • Nemoda Z, Sahin-Toth M. 2006. Chymotrypsin C (caldecrin) stimulates autoactivation of human cationic trypsinogen. J Biol Chem. 281(17):11879–11886.
  • Neoptolemos JP, Kemppainen EA, Mayer JM, Fitzpatrick JM, Raraty MG, Slavin J, Beger HG, Hietaranta AJ, Puolakkainen PA. 2000. Early prediction of severity in acute pancreatitis by urinary trypsinogen activation peptide: a multicentre study. Lancet. 355(9219):1955–1960.
  • Netzel-Arnett S, Currie BM, Szabo R, Lin CY, Chen LM, Chai KX, Antalis TM, Bugge TH, List K. 2006. Evidence for a matriptase-prostasin proteolytic cascade regulating terminal epidermal differentiation. J Biol Chem. 281(44):32941–32945.
  • Netzel-Arnett S, Hooper JD, Szabo R, Madison EL, Quigley JP, Bugge TH, Antalis TM. 2003. Membrane anchored serine proteases: a rapidly expanding group of cell surface proteolytic enzymes with potential roles in cancer. Cancer Metastasis Rev. 22(2–3):237–258.
  • Nguyen G, Delarue F, Burckle C, Bouzhir L, Giller T, Sraer JD. 2002. Pivotal role of the renin/prorenin receptor in angiotensin II production and cellular responses to renin. J Clin Invest. 109(11):1417–1427.
  • Niizuma H, Cheng EH, Hsieh JJ. 2015. Taspase 1: a protease with many biological surprises. Mol Cell Oncol. 2(4):e999513.
  • Nour N, Mayer G, Mort JS, Salvas A, Mbikay M, Morrison CJ, Overall CM, Seidah NG. 2005. The cysteine-rich domain of the secreted proprotein convertases PC5A and PACE4 functions as a cell surface anchor and interacts with tissue inhibitors of metalloproteinases. MBoC. 16(11):5215–5226.
  • Novinec M, Kovacic L, Lenarcic B, Baici A. 2010. Conformational flexibility and allosteric regulation of cathepsin K. Biochem J. 429(2):379–389.
  • Novinec M, Lenarcic B, Turk B. 2014. Cysteine cathepsin activity regulation by glycosaminoglycans. Biomed Res Int. 2014:1–9.
  • Oberst A, Pop C, Tremblay AG, Blais V, Denault JB, Salvesen GS, Green DR. 2010. Inducible dimerization and inducible cleavage reveal a requirement for both processes in caspase-8 activation. J Biol Chem. 285(22):16632–16642.
  • Oberst MD, Williams CA, Dickson RB, Johnson MD, Lin CY. 2003. The activation of matriptase requires its noncatalytic domains, serine protease domain, and its cognate inhibitor. J Biol Chem. 278(29):26773–26779.
  • Ogata Y, Enghild JJ, Nagase H. 1992. Matrix metalloproteinase 3 (stromelysin) activates the precursor for the human matrix metalloproteinase 9. J Biol Chem. 267(6):3581–3584.
  • Ohler A, Debela M, Wagner S, Magdolen V, Becker-Pauly C. 2010. Analyzing the protease web in skin: meprin metalloproteases are activated specifically by KLK4, 5 and 8 vice versa leading to processing of proKLK7 thereby triggering its activation. Biol Chem. 391(4):455–460.
  • Okada Y, Gonoji Y, Naka K, Tomita K, Nakanishi I, Iwata K, Yamashita K, Hayakawa T. 1992. Matrix metalloproteinase 9 (92-kDa gelatinase/type IV collagenase) from HT 1080 human fibrosarcoma cells. Purification and activation of the precursor and enzymic properties. J Biol Chem. 267(30):21712–21719.
  • Okada Y, Nakanishi I. 1989. Activation of matrix metalloproteinase 3 (stromelysin) and matrix metalloproteinase 2 ('gelatinase') by human neutrophil elastase and cathepsin G. FEBS Lett. 249(2):353–356.
  • Okumura Y, Sato H, Seiki M, Kido H. 1997. Proteolytic activation of the precursor of membrane type 1 matrix metalloproteinase by human plasmin. A possible cell surface activator. FEBS Lett. 402(2–3):181–184.
  • Overgaard MT, Boldt HB, Laursen LS, Sottrup-Jensen L, Conover CA, Oxvig C. 2001. Pregnancy-associated plasma protein-A2 (PAPP-A2), a novel insulin-like growth factor-binding protein-5 proteinase. J Biol Chem. 276(24):21849–21853.
  • Oxvig C, Sand O, Kristensen T, Gleich GJ, Sottrup-Jensen L. 1993. Circulating human pregnancy-associated plasma protein-A is disulfide-bridged to the proform of eosinophil major basic protein. J Biol Chem. 268(17):12243–12246.
  • Pal A, Kraetzner R, Gruene T, Grapp M, Schreiber K, Gronborg M, Urlaub H, Becker S, Asif AR, Gartner J, et al. 2009. Structure of tripeptidyl-peptidase I provides insight into the molecular basis of late infantile neuronal ceroid lipofuscinosis. J Biol Chem. 284(6):3976–3984.
  • Pande S, Lakshminarasimhan D, Guo HC. 2017. Crystal structure of a mutant glycosylasparaginase shedding light on aspartylglycosaminuria-causing mechanism as well as on hydrolysis of non-chitobiose substrate. Mol Genet Metab. 121(2):150–156.
  • Panteleev MA, Saenko EL, Ananyeva NM, Ataullakhanov FI. 2004. Kinetics of Factor X activation by the membrane-bound complex of Factor IXa and Factor VIIIa. Biochem J. 381(3):779–794.
  • Papayannopoulos V, Zychlinsky A. 2009. NETs: a new strategy for using old weapons. Trends Immunol. 30(11):513–521.
  • Pei D. 1999a. Identification and characterization of the fifth membrane-type matrix metalloproteinase MT5-MMP. J Biol Chem. 274(13):8925–8932.
  • Pei D. 1999b. Leukolysin/MMP25/MT6-MMP: a novel matrix metalloproteinase specifically expressed in the leukocyte lineage. Cell Res. 9(4):291–303.
  • Pei D, Kang T, Qi H. 2000. Cysteine array matrix metalloproteinase (CA-MMP)/MMP-23 is a type II transmembrane matrix metalloproteinase regulated by a single cleavage for both secretion and activation. J Biol Chem. 275(43):33988–33997.
  • Pei D, Weiss SJ. 1995. Furin-dependent intracellular activation of the human stromelysin-3 zymogen. Nature. 375(6528):244–247.
  • Peppin GJ, Weiss SJ. 1986. Activation of the endogenous metalloproteinase, gelatinase, by triggered human neutrophils. Proc Natl Acad Sci U S A. 83(12):4322–4326.
  • Peter ME, Krammer PH. 2003. The CD95(APO-1/Fas) DISC and beyond. Cell Death Differ. 10(1):26–35.
  • Pham CT, Ley TJ. 1999. Dipeptidyl peptidase I is required for the processing and activation of granzymes A and B in vivo. Proc Natl Acad Sci U S A. 96(15):8627–8632.
  • Phillips MA, Rutter WJ. 1996. Role of the prodomain in folding and secretion of rat pancreatic carboxypeptidase A1. Biochemistry. 35(21):6771–6776.
  • Ponder KG, Boise LH. 2019. The prodomain of caspase-3 regulates its own removal and caspase activation. Cell Death Discov. 5:56
  • Pop C, Timmer J, Sperandio S, Salvesen GS. 2006. The apoptosome activates caspase-9 by dimerization. Mol Cell. 22(2):269–275.
  • Popovic T, Brzin J, Kos J, Lenarcic B, Machleidt W, Ritonja A, Hanada K, Turk V. 1988. A new purification procedure of human kidney cathepsin H, its properties and kinetic data. Biol Chem Hoppe-Seyler. 369 Suppl:175–183.
  • Porter S, Clark IM, Kevorkian L, Edwards DR. 2005. The ADAMTS metalloproteinases. Biochem J. 386(1):15–27.
  • Proba K, Gschwend TP, Sonderegger P. 1998. Cloning and sequencing of the cDNA encoding human neurotrypsin. Biochim Biophys Acta. 1396(2):143–147.
  • Proost P, Struyf S, Van Damme J, Fiten P, Ugarte-Berzal E, Opdenakker G. 2017. Chemokine isoforms and processing in inflammation and immunity. J Autoimmun. 85:45–57.
  • Puente XS, Sanchez LM, Overall CM, Lopez-Otin C. 2003. Human and mouse proteases: a comparative genomic approach. Nat Rev Genet. 4(7):544–558.
  • Pullikotil P, Vincent M, Nichol ST, Seidah NG. 2004. Development of protein-based inhibitors of the proprotein of convertase SKI-1/S1P: processing of SREBP-2, ATF6, and a viral glycoprotein. J Biol Chem. 279(17):17338–17347.
  • Pungercar JR, Caglic D, Sajid M, Dolinar M, Vasiljeva O, Pozgan U, Turk D, Bogyo M, Turk V, Turk B. 2009. Autocatalytic processing of procathepsin B is triggered by proenzyme activity. FEBS J. 276(3):660–668.
  • Qin H, Srinivasula SM, Wu G, Fernandes-Alnemri T, Alnemri ES, Shi Y. 1999. Structural basis of procaspase-9 recruitment by the apoptotic protease-activating factor 1. Nature. 399(6736):549–557.
  • Ra HJ, Harju-Baker S, Zhang F, Linhardt RJ, Wilson CL, Parks WC. 2009. Control of promatrilysin (MMP7) activation and substrate-specific activity by sulfated glycosaminoglycans. J Biol Chem. 284(41):27924–27932.
  • Radcliffe R, Nemerson Y. 1975. Activation and control of factor VII by activated factor X and thrombin. Isolation and characterization of a single chain form of factor VII. J Biol Chem. 250(2):388–395.
  • Ramage P, Cheneval D, Chvei M, Graff P, Hemmig R, Heng R, Kocher HP, Mackenzie A, Memmert K, Revesz L. 1995. Expression, refolding, and autocatalytic proteolytic processing of the interleukin-1 beta-converting enzyme precursor. J Biol Chem. 270(16):9378–9383.
  • Ramos-DeSimone N, Hahn-Dantona E, Sipley J, Nagase H, French DL, Quigley JP. 1999. Activation of matrix metalloproteinase-9 (MMP-9) via a converging plasmin/stromelysin-1 cascade enhances tumor cell invasion. J Biol Chem. 274(19):13066–13076.
  • Rao NV, Rao GV, Marshall BC, Hoidal JR. 1996. Biosynthesis and processing of proteinase 3 in U937 cells. Processing pathways are distinct from those of cathepsin G. J Biol Chem. 271(6):2972–2978.
  • Rawlings ND, Waller M, Barrett AJ, Bateman A. 2014. MEROPS: the database of proteolytic enzymes, their substrates and inhibitors. Nucleic Acids Res. 42:503–509.
  • Renatus M, Stennicke HR, Scott FL, Liddington RC, Salvesen GS. 2001. Dimer formation drives the activation of the cell death protease caspase 9. Proc Natl Acad Sci USA. 98(25):14250–14255.
  • Reudelhuber TL, Brechler V, Jutras I, Mercure C, Methot D. 1998. Proteolytic and non-proteolytic activation of prorenin. Adv Exp Med Biol. 436:229–238.
  • Richter C, Tanaka T, Yada RY. 1998. Mechanism of activation of the gastric aspartic proteinases: pepsinogen, progastricsin and prochymosin. Biochem J. 335 (3):481–490.
  • Ricklin D, Reis ES, Mastellos DC, Gros P, Lambris JD. 2016. Complement component C3 Neuronal ceroid-lipofuscinoses. GeneReviews. The “‘Swiss Army Knife’ of innate immunity and host defense”. Immunol Rev. 274(1):33–58.
  • Riedl SJ, Fuentes-Prior P, Renatus M, Kairies N, Krapp S, Huber R, Salvesen GS, Bode W. 2001. Structural basis for the activation of human procaspase-7. Proc Natl Acad Sci USA. 98(26):14790–14795.
  • Ritonja A, Popovic T, Kotnik M, Machleidt W, Turk V. 1988. Amino acid sequences of the human kidney cathepsins H and L. FEBS Lett. 228(2):341–345.
  • Rodriguez J, Lazebnik Y. 1999. Caspase-9 and APAF-1 form an active holoenzyme. Genes Dev. 13(24):3179–3184.
  • Rodriguez-Manzaneque JC, Milchanowski AB, Dufour EK, Leduc R, Iruela-Arispe ML. 2000. Characterization of METH-1/ADAMTS1 processing reveals two distinct active forms. J Biol Chem. 275(43):33471–33479.
  • Roghani M, Becherer JD, Moss ML, Atherton RE, Erdjument-Bromage H, Arribas J, Blackburn RK, Weskamp G, Tempst P, Blobel CP. 1999. Metalloprotease-disintegrin MDC9: intracellular maturation and catalytic activity. J Biol Chem. 274(6):3531–3540.
  • Romisch J. 2002. Factor VII activating protease (FSAP): a novel protease in hemostasis. Biol Chem. 383(7–8):1119–1124.
  • Rosmann S, Hahn D, Lottaz D, Kruse MN, Stöcker W, Sterchi EE. 2002. Activation of human meprin-alpha in a cell culture model of colorectal cancer is triggered by the plasminogen-activating system. J Biol Chem. 277(43):40650–40658.
  • Rossi A, Deveraux Q, Turk B, Sali A. 2004. Comprehensive search for cysteine cathepsins in the human genome. Biol Chem. 385(5):363–372.
  • Rousselet E, Benjannet S, Hamelin J, Canuel M, Seidah NG. 2011. The proprotein convertase PC7: unique zymogen activation and trafficking pathways. J Biol Chem. 286(4):2728–2738.
  • Roversi P, Johnson S, Caesar JJ, McLean F, Leath KJ, Tsiftsoglou SA, Morgan BP, Harris CL, Sim RB, Lea SM. 2011. Structural basis for complement factor I control and its disease-associated sequence polymorphisms. Proc Natl Acad Sci USA. 108(31):12839–12844.
  • Rovery N, Fabre C, Desnuelle P. 1953. Study of the activation of bovine chymotrypsinogen and trypsinogen by determination of the N-terminal residues in these proteins and their corresponding enzymes. Biochim Biophys Acta. 12(1–2):547–559.
  • Rozman J, Stojan J, Kuhelj R, Turk V, Turk B. 1999. Autocatalytic processing of recombinant human procathepsin B is a bimolecular process. FEBS Lett. 459(3):358–362.
  • Sage J, Mallevre F, Barbarin-Costes F, Samsonov SA, Gehrcke JP, Pisabarro MT, Perrier E, Schnebert S, Roget A, Livache T, et al. 2013. Binding of chondroitin 4-sulfate to cathepsin S regulates its enzymatic activity. Biochemistry. 52(37):6487–6498.
  • Sakai K, Ren S, Schwartz LB. 1996. A novel heparin-dependent processing pathway for human tryptase. Autocatalysis followed by activation with dipeptidyl peptidase I. J Clin Invest. 97(4):988–995.
  • Sang QX, Birkedal-Hansen H, Van Wart HE. 1995. Proteolytic and non-proteolytic activation of human neutrophil progelatinase B. Biochim Biophys Acta. 1251(2):99–108.
  • Santagata S, Bhattacharyya D, Wang FH, Singha N, Hodtsev A, Spanopoulou E. 1999. Molecular cloning and characterization of a mouse homolog of bacterial ClpX, a novel mammalian class II member of the Hsp100/Clp chaperone family. J Biol Chem. 274(23):16311–16319.
  • Santamaria I, Velasco G, Pendas AM, Fueyo A, Lopez-Otin C. 1998. Cathepsin Z, a novel human cysteine proteinase with a short propeptide domain and a unique chromosomal location. J Biol Chem. 273(27):16816–16823.
  • Santamaria I, Velasco G, Pendas AM, Paz A, Lopez-Otin C. 1999. Molecular cloning and structural and functional characterization of human cathepsin F, a new cysteine proteinase of the papain family with a long propeptide domain. J Biol Chem. 274(20):13800–13809.
  • Sarkany RP, Moreland BH. 1985. Enhancement of the autocatalytic activation of trypsinogen to trypsin by bile and bile acids. Biochim Biophys Acta. 839(3):262–267.
  • Sato H, Kinoshita T, Takino T, Nakayama K, Seiki M. 1996. Activation of a recombinant membrane type 1-matrix metalloproteinase (MT1-MMP) by furin and its interaction with tissue inhibitor of metalloproteinases (TIMP)-2. FEBS Lett. 393(1):101–104.
  • Saunders WB, Bayless KJ, Davis GE. 2005. MMP-1 activation by serine proteases and MMP-10 induces human capillary tubular network collapse and regression in 3D collagen matrices. J Cell Sci. 118(10):2325–2340.
  • Scannevin RH, Alexander R, Haarlander TM, Burke SL, Singer M, Huo C, Zhang YM, Maguire D, Spurlino J, Deckman I, et al. 2017. Discovery of a highly selective chemical inhibitor of matrix metalloproteinase-9 (MMP-9) that allosterically inhibits zymogen activation. J Biol Chem. 292(43):17963–17974.
  • Schauer-Vukasinovic V, Bur D, Kitas E, Schlatter D, Rosse G, Lahm HW, Giller T. 2000. Purification and characterization of active recombinant human napsin A. Eur J Biochem. 267(9):2573–2580.
  • Schauer-Vukasinovic V, Bur D, Kling D, Gruninger F, Giller T. 1999. Human napsin A: expression, immunochemical detection, and tissue localization. FEBS Lett. 462(1–2):135–139.
  • Schilling K, Korner A, Sehmisch S, Kreusch A, Kleint R, Benedix Y, Schlabrakowski A, Wiederanders B. 2009. Selectivity of propeptide-enzyme interaction in cathepsin L-like cysteine proteases. Biol Chem. 390(2):167–174.
  • Schlomann U, Wildeboer D, Webster A, Antropova O, Zeuschner D, Knight CG, Docherty AJ, Lambert M, Skelton L, Jockusch H, et al. 2002. The metalloprotease disintegrin ADAM8. Processing by autocatalysis is required for proteolytic activity and cell adhesion. J Biol Chem. 277(50):48210–48219.
  • Schwert GW. 1949. The molecular size and shape of the pancreatic proteases; sedimentation studies on chymotrypsinogen and on alpha- and gamma-chymotrypsin. J Biol Chem. 179(2):655–664.
  • Schwert GW, Kaufman S. 1949. The substrate specificity and sedimentation behavior of delta-chymotrypsin. J Biol Chem. 180(2):517–523.
  • Scott FL, Stec B, Pop C, Dobaczewska MK, Lee JJ, Monosov E, Robinson H, Salvesen GS, Schwarzenbacher R, Riedl SJ. 2009. The Fas-FADD death domain complex structure unravels signalling by receptor clustering. Nature. 457(7232):1019–1022.
  • Seals DF, Courtneidge SA. 2003. The ADAMs family of metalloproteases: multidomain proteins with multiple functions. Genes Dev. 17(1):7–30.
  • Segal AW. 2005. How neutrophils kill microbes. Annu Rev Immunol. 23(1):197–223.
  • Seidah NG, Benjannet S, Wickham L, Marcinkiewicz J, Jasmin SB, Stifani S, Basak A, Prat A, Chretien M. 2003. The secretory proprotein convertase neural apoptosis-regulated convertase 1 (NARC-1): liver regeneration and neuronal differentiation. Proc Natl Acad Sci USA. 100(3):928–933.
  • Seidah NG, Day R, Hamelin J, Gaspar A, Collard MW, Chretien M. 1992. Testicular expression of PC4 in the rat: molecular diversity of a novel germ cell-specific Kex2/subtilisin-like proprotein convertase. Mol Endocrinol. 6(10):1559–1570.
  • Seidah NG, Hamelin J, Mamarbachi M, Dong W, Tardos H, Mbikay M, Chretien M, Day R. 1996. cDNA structure, tissue distribution, and chromosomal localization of rat PC7, a novel mammalian proprotein convertase closest to yeast kexin-like proteinases. Proc Natl Acad Sci USA. 93(8):3388–3393.
  • Seidah NG, Prat A. 2012. The biology and therapeutic targeting of the proprotein convertases. Nat Rev Drug Discov. 11(5):367–383.
  • Seidah NG, Sadr MS, Chretien M, Mbikay M. 2013. The multifaceted proprotein convertases: their unique, redundant, complementary, and opposite functions. J Biol Chem. 288(30):21473–21481.
  • Sela-Passwell N, Rosenblum G, Shoham T, Sagi I. 2010. Structural and functional bases for allosteric control of MMP activities: can it pave the path for selective inhibition? Biochim Biophys Acta. 1803(1):29–38.
  • Shapiro SD, Fliszar CJ, Broekelmann TJ, Mecham RP, Senior RM, Welgus HG. 1995. Activation of the 92-kDa gelatinase by stromelysin and 4-aminophenylmercuric acetate. Differential processing and stabilization of the carboxyl-terminal domain by tissue inhibitor of metalloproteinases (TIMP). J Biol Chem. 270(11):6351–6356.
  • Shapiro SD, Kobayashi DK, Ley TJ. 1993. Cloning and characterization of a unique elastolytic metalloproteinase produced by human alveolar macrophages. J Biol Chem. 268(32):23824–23829.
  • Shi Y. 2004. Caspase activation: revisiting the induced proximity model. Cell. 117(7):855–858.
  • Shi GP, Chapman HA, Bhairi SM, DeLeeuw C, Reddy VY, Weiss SJ. 1995. Molecular cloning of human cathepsin O, a novel endoproteinase and homologue of rabbit OC2. FEBS Lett. 357(2):129–134.
  • Shimomura T, Kondo J, Ochiai M, Naka D, Miyazawa K, Morimoto Y, Kitamura N. 1993. Activation of the zymogen of hepatocyte growth factor activator by thrombin. J Biol Chem. 268(30):22927–22932.
  • Shinagawa T, Do YS, Baxter JD, Carilli C, Schilling J, Hsueh WA. 1990. Identification of an enzyme in human kidney that correctly processes prorenin. Proc Natl Acad Sci USA. 87(5):1927–1931.
  • Simon DJ, Weimer RM, McLaughlin T, Kallop D, Stanger K, Yang J, O'Leary DDM, Hannoush RN, Tessier-Lavigne M. 2012. A caspase cascade regulating developmental axon degeneration. J Neurosci. 32(49):17540–17553.
  • Sivaraman J, Lalumiere M, Menard R, Cygler M. 1999. Crystal structure of wild-type human procathepsin K. Protein Sci. 8(2):283–290.
  • Sivaraman J, Nagler DK, Zhang R, Menard R, Cygler M. 2000. Crystal structure of human procathepsin X: a cysteine protease with the proregion covalently linked to the active site cysteine. J Mol Biol. 295(4):939–951.
  • Skorko-Glonek J, Zurawa-Janicka D, Koper T, Jarzab M, Figaj D, Glaza P, Lipinska B. 2013. HtrA protease family as therapeutic targets. Curr Pharm Des. 19(6):977–1009.
  • Slee EA, Harte MT, Kluck RM, Wolf BB, Casiano CA, Newmeyer DD, Wang HG, Reed JC, Nicholson DW, Alnemri ES. 1999. Ordering the cytochrome c-initiated caspase cascade: hierarchical activation of caspases-2, -3, -6, -7, -8, and -10 in a caspase-9-dependent manner. J Cell Biol. 144(2):281–292.
  • Smith SA, Travers RJ, Morrissey JH. 2015. How it all starts: initiation of the clotting cascade. Crit Rev Biochem Mol Biol. 50(4):326–336.
  • Smyth MJ, McGuire MJ, Thia KY. 1995. Expression of recombinant human granzyme B. A processing and activation role for dipeptidyl peptidase I. J Immunol. 154(12):6299–6305.
  • Smyth MJ, O'Connor MD, Trapani JA, Kershaw MH, Brinkworth RI. 1996. A novel substrate-binding pocket interaction restricts the specificity of the human NK cell-specific serine protease, Met-ase-1. J Immunol. 156(11):4174–4181.
  • Somerville RP, Jungers KA, Apte SS. 2004a. Discovery and characterization of a novel, widely expressed metalloprotease, ADAMTS10, and its proteolytic activation. J Biol Chem. 279(49):51208–51217.
  • Somerville RP, Longpre JM, Apel ED, Lewis RM, Wang LW, Sanes JR, Leduc R, Apte SS. 2004b. ADAMTS7B, the full-length product of the ADAMTS7 gene, is a chondroitin sulfate proteoglycan containing a mucin domain. J Biol Chem. 279(34):35159–35175.
  • Springman EB, Angleton EL, Birkedal-Hansen H, Van Wart HE. 1990. Multiple modes of activation of latent human fibroblast collagenase: evidence for the role of a Cys73 active-site zinc complex in latency and a “cysteine switch” mechanism for activation. Proc Natl Acad Sci USA. 87(1):364–368.
  • Springman EB, Dikov MM, Serafin WE. 1995. Mast cell procarboxypeptidase A. Molecular modeling and biochemical characterization of its processing within secretory granules. J Biol Chem. 270(3):1300–1307.
  • Spycher SE, Nick H, Rickli EE. 1986. Human complement component C1s. Partial sequence determination of the heavy chain and identification of the peptide bond cleaved during activation. Eur J Biochem. 156(1):49–57.
  • Sripa J, Laha T, To J, Brindley PJ, Sripa B, Kaewkes S, Dalton JP, Robinson MW. 2010. Secreted cysteine proteases of the carcinogenic liver fluke, Opisthorchis viverrini: regulation of cathepsin F activation by autocatalysis and trans-processing by cathepsin B. Cell Microbiol. 12(6):781–795.
  • Stanger K, Steffek M, Zhou L, Pozniak CD, Quan C, Franke Y, Tom J, Tam C, Krylova I, Elliott JM, et al. 2012. Allosteric peptides bind a caspase zymogen and mediate caspase tetramerization. Nat Chem Biol. 8(7):655–660.
  • Stawowy P, Meyborg H, Stibenz D, Stawowy NBP, Roser M, Thanabalasingam U, Veinot JP, Chrétien M, Seidah NG, Fleck E, et al. 2005. Furin-like proprotein convertases are central regulators of the membrane type matrix metalloproteinase-pro-matrix metalloproteinase-2 proteolytic cascade in atherosclerosis. Circulation. 111(21):2820–2827.
  • Steiner DF. 1998. The proprotein convertases. Curr Opin Chem Biol. 2(1):31–39.
  • Stennicke HR, Deveraux QL, Humke EW, Reed JC, Dixit VM, Salvesen GS. 1999. Caspase-9 can be activated without proteolytic processing. J Biol Chem. 274(13):8359–8362.
  • Stennicke HR, Jurgensmeier JM, Shin H, Deveraux Q, Wolf BB, Yang X, Zhou Q, Ellerby HM, Ellerby LM, Bredesen D, et al. 1998. Pro-caspase-3 is a major physiologic target of caspase-8. J Biol Chem. 273(42):27084–27090.
  • Stijnen P, Ramos-Molina B, O'Rahilly S, Creemers JWM. 2016. PCSK1 mutations and human endocrinopathies: from obesity to gastrointestinal disorders. Endocr Rev. 37(4):347–371.
  • Suzuki Y, Imai Y, Nakayama H, Takahashi K, Takio K, Takahashi R. 2001. A serine protease, HtrA2, is released from the mitochondria and interacts with XIAP, inducing cell death. Mol Cell. 8(3):613–621.
  • Syrovets T, Lunov O, Simmet T. 2012. Plasmin as a proinflammatory cell activator. J Leukoc Biol. 92(3):509–519.
  • Szabo R, Netzel-Arnett S, Hobson JP, Antalis TM, Bugge TH. 2005. Matriptase-3 is a novel phylogenetically preserved membrane-anchored serine protease with broad serpin reactivity. Biochem J. 390(1):231–242.
  • Szabo A, Pilsak C, Bence M, Witt H, Sahin-Toth M. 2016. Complex formation of human proelastases with procarboxypeptidases A1 and A2. J Biol Chem. 291(34):17706–17716.
  • Szmola R, Bence M, Carpentieri A, Szabo A, Costello CE, Samuelson J, Sahin-Toth M. 2011. Chymotrypsin C is a co-activator of human pancreatic procarboxypeptidases A1 and A2. J Biol Chem. 286(3):1819–1827.
  • Takada F, Takayama Y, Hatsuse H, Kawakami M. 1993. A new member of the C1s family of complement proteins found in a bactericidal factor, Ra-reactive factor, in human serum. Biochem Biophys Res Commun. 196(2):1003–1009.
  • Takeshima H, Sakaguchi M, Mihara K, Murakami K, Omura T. 1995. Intracellular targeting of lysosomal cathepsin D in COS cells. J Biochem. 118(5):981–988.
  • Tan AK, Eaton DL. 1995. Activation and characterization of procarboxypeptidase B from human plasma. Biochemistry. 34(17):5811–5816.
  • Tanaka K. 2009. The proteasome: overview of structure and functions. Proc Jpn Acad Ser B. 85(1):12–36.
  • Tanco S, Zhang X, Morano C, Aviles FX, Lorenzo J, Fricker LD. 2010. Characterization of the substrate specificity of human carboxypeptidase A4 and implications for a role in extracellular peptide processing. J Biol Chem. 285(24):18385–18396.
  • Taylor NA, Shennan KI, Cutler DF, Docherty K. 1997. Mutations within the propeptide, the primary cleavage site or the catalytic site, or deletion of C-terminal sequences, prevents secretion of proPC2 from transfected COS-7 cells. Biochem J. 321 (2):367–373.
  • Tchougounova E, Lundequist A, Fajardo I, Winberg JO, Abrink M, Pejler G. 2005. A key role for mast cell chymase in the activation of pro-matrix metalloprotease-9 and pro-matrix metalloprotease-2. J Biol Chem. 280(10):9291–9296.
  • Thiel S, Vorup-Jensen T, Stover CM, Schwaeble W, Laursen SB, Poulsen K, Willis AC, Eggleton P, Hansen S, Holmskov U. 1997. A second serine protease associated with mannan-binding lectin that activates complement. Nature. 386(6624):506–510.
  • Thielens NM, Villiers MB, Reboul A, Villiers CL, Colomb MG. 1982. Human complement subcomponent C2: purification and proteolytic cleavage in fluid phase by C1s, C1r2-C1s2 and C1. FEBS Lett. 141(1):19–24.
  • Thornberry NA, Rano TA, Peterson EP, Rasper DM, Timkey T, Garcia-Calvo M, Houtzager VM, Nordstrom PA, Roy S, Vaillancourt JP, et al. 1997. A combinatorial approach defines specificities of members of the caspase family and granzyme B. Functional relationships established for key mediators of apoptosis. J Biol Chem. 272(29):17907–17911.
  • Ting JP, Willingham SB, Bergstralh DT. 2008. NLRs at the intersection of cell death and immunity. Nat Rev Immunol. 8(5):372–379.
  • Tomkinson B. 1999. Tripeptidyl peptidases: enzymes that count. Trends Biochem Sci. 24(9):355–359.
  • Tomomura A, Fukushige T, Tomomura M, Noikura T, Nishii Y, Saheki T. 1993. Caldecrin proform requires trypsin activation for the acquisition of serum calcium-decreasing activity. FEBS Lett. 335(2):213–216.
  • Trivedi NN, Raymond WW, Caughey GH. 2008. Chimerism, point mutation, and truncation dramatically transformed mast cell delta-tryptases during primate evolution. J Allergy Clin Immunol. 121(5):1262–1268.
  • Truebestein L, Tennstaedt A, Monig T, Krojer T, Canellas F, Kaiser M, Clausen T, Ehrmann M. 2011. Substrate-induced remodeling of the active site regulates human HTRA1 activity. Nat Struct Mol Biol. 18(3):386–388.
  • Turk B. 2006. Targeting proteases: successes, failures and future prospects. Nat Rev Drug Discov. 5(9):785–799.
  • Turk D, Janjic V, Stern I, Podobnik M, Lamba D, Dahl SW, Lauritzen C, Pedersen J, Turk V, Turk B. 2001. Structure of human dipeptidyl peptidase I (cathepsin C): exclusion domain added to an endopeptidase framework creates the machine for activation of granular serine proteases. EMBO J. 20(23):6570–6582.
  • Turk D, Podobnik M, Kuhelj R, Dolinar M, Turk V. 1996. Crystal structures of human procathepsin B at 3.2 and 3.3 Angstroms resolution reveal an interaction motif between a papain-like cysteine protease and its propeptide. FEBS Lett. 384(3):211–214.
  • Turk B, Turk V. 2009. Lysosomes as “‘suicide bags’ in cell death: myth or reality?” J Biol Chem. 284(33):21783–21787.
  • Turk B, Turk D, Turk V. 2012. Protease signalling: the cutting edge. EMBO J. 31(7):1630–1643.
  • Turpeinen H, Kukkurainen S, Pulkkinen K, Kauppila T, Ojala K, Hytonen VP, Pesu M. 2011. Identification of proprotein convertase substrates using genome-wide expression correlation analysis. BMC Genomics. 12(1):618.
  • Ueno T, Linder S, Na CL, Rice WR, Johansson J, Weaver TE. 2004. Processing of pulmonary surfactant protein B by napsin and cathepsin H. J Biol Chem. 279(16):16178–16184.
  • Urata H, Karnik SS, Graham RM, Husain A. 1993. Dipeptide processing activates recombinant human prochymase. J Biol Chem. 268(32):24318–24322.
  • Urata H, Kinoshita A, Perez DM, Misono KS, Bumpus FM, Graham RM, Husain A. 1991. Cloning of the gene and cDNA for human heart chymase. J Biol Chem. 266(26):17173–17179.
  • Uria JA, Lopez-Otin C. 2000. Matrilysin-2, a new matrix metalloproteinase expressed in human tumors and showing the minimal domain organization required for secretion, latency, and activity. Cancer Res. 60(17):4745–4751.
  • Vahedi F, Fraleigh N, Vlasschaert C, McElhaney J, Hanifi-Moghaddam P. 2014. Human granzymes: related but far apart. Med Hypotheses. 83(6):688–693.
  • Van de Ven WJ, Roebroek AJ, Van Duijnhoven HL. 1993. Structure and function of eukaryotic proprotein processing enzymes of the subtilisin family of serine proteases. Crit Rev Oncog. 4(2):115–136.
  • Van Wart HE, Birkedal-Hansen H. 1990. The cysteine switch: a principle of regulation of metalloproteinase activity with potential applicability to the entire matrix metalloproteinase gene family. Proc Natl Acad Sci USA. 87(14):5578–5582.
  • Vandooren J, Born B, Solomonov I, Zajac E, Saldova R, Senske M, Ugarte-Berzal E, Martens E, Van den Steen PE, Van Damme J, et al. 2015. Circular trimers of gelatinase B/matrix metalloproteinase-9 constitute a distinct population of functional enzyme molecules differentially regulated by tissue inhibitor of metalloproteinases-1. Biochem J. 465(2):259–270.
  • Vandooren J, Van den Steen PE, Opdenakker G. 2013. Biochemistry and molecular biology of gelatinase B or matrix metalloproteinase-9 (MMP-9): the next decade. Crit Rev Biochem Mol Biol. 48(3):222–272.
  • Vasiljeva O, Dolinar M, Pungercar JR, Turk V, Turk B. 2005. Recombinant human procathepsin S is capable of autocatalytic processing at neutral pH in the presence of glycosaminoglycans. FEBS Lett. 579(5):1285–1290.
  • Vasiljeva O, Dolinar M, Turk V, Turk B. 2003. Recombinant human cathepsin H lacking the mini chain is an endopeptidase. Biochemistry. 42(46):13522–13528.
  • Velasco G, Ferrando AA, Puente XS, Sanchez LM, Lopez-Otin C. 1994. Human cathepsin O. Molecular cloning from a breast carcinoma, production of the active enzyme in Escherichia coli, and expression analysis in human tissues. J Biol Chem. 269(43):27136–27142.
  • Velasco G, Cal S, Quesada V, Sánchez LM, López-Otı́n C. 2002. Matriptase-2, a membrane-bound mosaic serine proteinase predominantly expressed in human liver and showing degrading activity against extracellular matrix proteins. J Biol Chem. 277(40):37637–37646.
  • Vendrell J, Guasch A, Coll M, Villegas V, Billeter M, Wider G, Huber R, Wuthrich K, Aviles FX. 1992. Pancreatic procarboxypeptidases: their activation processes related to the structural features of the zymogens and activation segments. Biol Chem Hoppe-Seyler. 373(7):387–392.
  • Vendrell J, Querol E, Aviles FX. 2000. Metallocarboxypeptidases and their protein inhibitors. Structure, function and biomedical properties. Biochim Biophys Acta. 1477(1–2):284–298.
  • Verma S, Dixit R, Pandey KC. 2016. Cysteine proteases: modes of activation and future prospects as pharmacological targets. Front Pharmacol. 7:107
  • Vernet T, Berti PJ, de Montigny C, Musil R, Tessier DC, Menard R, Magny MC, Storer AC, Thomas DY. 1995. Processing of the papain precursor. The ionization state of a conserved amino acid motif within the Pro region participates in the regulation of intramolecular processing. J Biol Chem. 270(18):10838–10846.
  • Vetvicka V, Vetvickova J, Fusek M. 1999. Anti-human procathepsin D activation peptide antibodies inhibit breast cancer development. Breast Cancer Res Treat. 57(3):261–269.
  • Vigano E, Diamond CE, Spreafico R, Balachander A, Sobota RM, Mortellaro A. 2015. Human caspase-4 and caspase-5 regulate the one-step non-canonical inflammasome activation in monocytes. Nat Commun. 6:8761.
  • Voss OH, Batra S, Kolattukudy SJ, Gonzalez-Mejia ME, Smith JB, Doseff AI. 2007. Binding of caspase-3 prodomain to heat shock protein 27 regulates monocyte apoptosis by inhibiting caspase-3 proteolytic activation. J Biol Chem. 282(34):25088–25099.
  • Vu TK, Liu RW, Haaksma CJ, Tomasek JJ, Howard EW. 1997. Identification and cloning of the membrane-associated serine protease, hepsin, from mouse preimplantation embryos. J Biol Chem. 272(50):31315–31320.
  • Walker RK, Krishnaswamy S. 1994. The activation of prothrombin by the prothrombinase complex. The contribution of the substrate-membrane interaction to catalysis. J Biol Chem. 269(44):27441–27450.
  • Walus M, Kida E, Golabek AA. 2010. Functional consequences and rescue potential of pathogenic missense mutations in tripeptidyl peptidase I. Hum Mutat. 31(6):710–721.
  • Wang XJ, Cao Q, Liu X, Wang KT, Mi W, Zhang Y, Li LF, LeBlanc AC, Su XD. 2010. Crystal structures of human caspase 6 reveal a new mechanism for intramolecular cleavage self-activation. EMBO Rep. 11(11):841–847.
  • Wang Y, Guo HC. 2010. Crystallographic snapshot of glycosylasparaginase precursor poised for autoprocessing. J Mol Biol. 403(1):120–130.
  • Wang P, Tortorella M, England K, Malfait AM, Thomas G, Arner EC, Pei D. 2004. Proprotein convertase furin interacts with and cleaves pro-ADAMTS4 (Aggrecanase-1) in the trans-Golgi network. J Biol Chem. 279(15):15434–15440.
  • Weiss SJ, Peppin G, Ortiz X, Ragsdale C, Test ST. 1985. Oxidative autoactivation of latent collagenase by human neutrophils. Science. 227(4688):747–749.
  • Werb Z, Mainardi CL, Vater CA. Harris ED, Jr 1977. Endogenous activation of latent collagenase by rheumatoid synovial cells. Evidence for a role of plasminogen activator. N Engl J Med. 296(18):1017–1023.
  • Wex T, Buhling F, Wex H, Gunther D, Malfertheiner P, Weber E, Bromme D. 2001. Human cathepsin W, a cysteine protease predominantly expressed in NK cells, is mainly localized in the endoplasmic reticulum. J Immunol. 167(4):2172–2178.
  • Wex T, Levy B, Wex H, Bromme D. 2000. Human cathepsins W and F form a new subgroup of cathepsins that is evolutionary separated from the cathepsin B- and L-like cysteine proteases. Adv Exp Med Biol. 477:271–280.
  • Wex T, Wex H, Bromme D. 1999. The human cathepsin F gene – a fusion product between an ancestral cathepsin and cystatin gene. Biol Chem. 380(12):1439–1442.
  • Whitcomb DC. 1999. Hereditary pancreatitis: new insights into acute and chronic pancreatitis. Gut. 45(3):317–322.
  • Whitham SE, Murphy G, Angel P, Rahmsdorf HJ, Smith BJ, Lyons A, Harris TJ, Reynolds JJ, Herrlich P, Docherty AJ. 1986. Comparison of human stromelysin and collagenase by cloning and sequence analysis. Biochem J. 240(3):913–916.
  • Wiederanders B. 2000. The function of propeptide domains of cysteine proteinases. Adv Exp Med Biol. 477:261–270.
  • Wilkins-Port CE, Ye Q, Mazurkiewicz JE, Higgins PJ. 2009. TGF-beta1 + EGF-initiated invasive potential in transformed human keratinocytes is coupled to a plasmin/MMP-10/MMP-1-dependent collagen remodeling axis: role for PAI-1. Cancer Res. 69(9):4081–4091.
  • Will H, Atkinson SJ, Butler GS, Smith B, Murphy G. 1996. The soluble catalytic domain of membrane type 1 matrix metalloproteinase cleaves the propeptide of progelatinase A and initiates autoproteolytic activation. Regulation by TIMP-2 and TIMP-3. J Biol Chem. 271(29):17119–17123.
  • Williamson DM, Elferich J, Ramakrishnan P, Thomas G, Shinde U. 2013. The mechanism by which a propeptide-encoded pH sensor regulates spatiotemporal activation of furin. J Biol Chem. 288(26):19154–19165.
  • Williamson DM, Elferich J, Shinde U. 2015. Mechanism of fine-tuning pH sensors in proprotein convertases: identification of a pH-sensing histigine pair in the propeptide of proprotein convertase 1/3. J Biol Chem. 290(38):23214–23225.
  • Witt H, Luck W, Becker M. 1999. A signal peptide cleavage site mutation in the cationic trypsinogen gene is strongly associated with chronic pancreatitis. Gastroenterology. 117(1):7–10.
  • Witt H, Luck W, Hennies HC, Claßen M, Kage A, Laß U, Landt O, Becker M. 2000. Mutations in the gene encoding the serine protease inhibitor, Kazal type 1 are associated with chronic pancreatitis. Nat Genet. 25(2):213–216.
  • Wolters PJ, Pham CT, Muilenburg DJ, Ley TJ, Caughey GH. 2001. Dipeptidyl peptidase I is essential for activation of mast cell chymases, but not tryptases, in mice. J Biol Chem. 276(21):18551–18556.
  • Wong E, Maretzky T, Peleg Y, Blobel CP, Sagi I. 2015. The functional maturation of a disintegrin and metalloproteinase (ADAM) 9, 10, and 17 requires processing at a newly identified proprotein convertase (PC) cleavage site. J Biol Chem. 290(19):12135–12146.
  • Xue D, Shaham S, Horvitz HR. 1996. The Caenorhabditis elegans cell-death protein CED-3 is a cysteine protease with substrate specificities similar to those of the human CPP32 protease. Genes Dev. 10(9):1073–1083.
  • Yamaguchi N, Okui A, Yamada T, Nakazato H, Mitsui S. 2002. Spinesin/TMPRSS5, a novel transmembrane serine protease, cloned from human spinal cord. J Biol Chem. 277(9):6806–6812.
  • Yan R, Munzner JB, Shuck ME, Bienkowski MJ. 2001. BACE2 functions as an alternative alpha-secretase in cells. J Biol Chem. 276(36):34019–34027.
  • Yana I, Weiss SJ. 2000. Regulation of membrane type-1 matrix metalloproteinase activation by proprotein convertases. Mol Biol Cell. 11(7):2387–2401.
  • Yang X, Stennicke HR, Wang B, Green DR, Janicke RU, Srinivasan A, Seth P, Salvesen GS, Froelich CJ. 1998. Granzyme B mimics apical caspases. Description of a unified pathway for trans-activation of executioner caspase-3 and -7. J Biol Chem. 273(51):34278–34283.
  • Yasuda Y, Tsukuba T, Okamoto K, Kadowaki T, Yamamoto K. 2005. The role of the cathepsin E propeptide in correct folding, maturation and sorting to the endosome. J Biochem. 138(5):621–630.
  • Yasukawa K, Kusano M, Inouye K. 2007. A new method for the extracellular production of recombinant thermolysin by co-expressing the mature sequence and pro-sequence in Escherichia coli. Protein Eng Des Sel. 20(8):375–383.
  • Yasuoka S, Ohnishi T, Kawano S, Tsuchihashi S, Ogawara M, Masuda K, Yamaoka K, Takahashi M, Sano T. 1997. Purification, characterization, and localization of a novel trypsin-like protease found in the human airway. Am J Respir Cell Mol Biol. 16(3):300–308.
  • Yoon H, Blaber SI, Evans DM, Trim J, Juliano MA, Scarisbrick IA, Blaber M. 2008. Activation profiles of human kallikrein-related peptidases by proteases of the thrombostasis axis. Protein Sci. 17(11):1998–2007.
  • Yoon H, Blaber SI, Li W, Scarisbrick IA, Blaber M. 2013. Activation profiles of human kallikrein-related peptidases by matrix metalloproteinases. Biol Chem. 394(1):137–147.
  • Yoon H, Laxmikanthan G, Lee J, Blaber SI, Rodriguez A, Kogot JM, Scarisbrick IA, Blaber M. 2007. Activation profiles and regulatory cascades of the human kallikrein-related peptidases. J Biol Chem. 282(44):31852–31864.
  • Yousef GM, Diamandis EP. 2001. The new human tissue kallikrein gene family: structure, function, and association to disease. Endocr Rev. 22(2):184–204.
  • Yu JX, Chao L, Chao J. 1994. Prostasin is a novel human serine proteinase from seminal fluid. Purification, tissue distribution, and localization in prostate gland. J Biol Chem. 269(29):18843–18848.
  • Yu JX, Chao L, Chao J. 1995. Molecular cloning, tissue-specific expression, and cellular localization of human prostasin mRNA. J Biol Chem. 270(22):13483–13489.
  • Zaidi N, Kalbacher H. 2008. Cathepsin E: a mini review. Biochem Biophys Res Commun. 367(3):517–522.
  • Zajac E, Schweighofer B, Kupriyanova TA, Juncker-Jensen A, Minder P, Quigley JP, Deryugina EI. 2013. Angiogenic capacity of M1- and M2-polarized macrophages is determined by the levels of TIMP-1 complexed with their secreted proMMP-9. Blood. 122(25):4054–4067.
  • Zajc T, Suban D, Rajkovic J, Dolenc I. 2011. Baculoviral expression and characterization of human recombinant PGCP in the form of an active mature dimer and an inactive precursor protein. Protein Expr Purif. 75(2):119–126.
  • Zamolodchikova TS, Sokolova EA, Lu D, Sadler JE. 2000. Activation of recombinant proenteropeptidase by duodenase. FEBS Lett. 466(2–3):295–299.
  • Zhao Y, Lyons CE, Jr., Xiao A, Templeton DJ, Sang QA, Brew K, Hussaini IM. 2008. Urokinase directly activates matrix metalloproteinases-9: a potential role in glioblastoma invasion. Biochem Biophys Res Commun. 369(4):1215–1220.
  • Zheng X, Kitamoto Y, Sadler JE. 2009. Enteropeptidase, a type II transmembrane serine protease. Front Biosci (Elite Ed). 1:242–249.
  • Zheng X, Lu D, Sadler JE. 1999. Apical sorting of bovine enteropeptidase does not involve detergent-resistant association with sphingolipid-cholesterol rafts. J Biol Chem. 274(3):1596–1605.
  • Zhong M, Munzer JS, Basak A, Benjannet S, Mowla SJ, Decroly E, Chretien M, Seidah NG. 1999. The prosegments of furin and PC7 as potent inhibitors of proprotein convertases. In vitro and ex vivo assessment of their efficacy and selectivity. J Biol Chem. 274(48):33913–33920.
  • Zhu L, Tanimoto K, Robinsin S, Chen J, Witkowska E, Hall S, Le T, Denbesten PK, Li W. 2008. Comparative properties of recombinant human and bovine matrix metalloproteinase-20. Arch Oral Biol. 53(8):785–790.
  • Ziccardi RJ, Cooper NR. 1976. Activation of C1r by proteolytic cleavage. J Immunol. 116(2):504–509.
  • Zimmer M, Medcalf RL, Fink TM, Mattmann C, Lichter P, Jenne DE. 1992. Three human elastase-like genes coordinately expressed in the myelomonocyte lineage are organized as a single genetic locus on 19pter. Proc Natl Acad Sci U S A. 89(17):8215–8219.
  • Zurawa-Janicka D, Wenta T, Jarzab M, Skorko-Glonek J, Glaza P, Gieldon A, Ciarkowski J, Lipinska B. 2017. Structural insights into the activation mechanisms of human HtrA serine proteases. Arch Biochem Biophys. 621:6–23.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.